OriginClear (OCLN) 10-Q 21 Nov 19 2019 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2019	Nov. 19, 2019
Document and Entity Information [Abstract]
Entity Registrant Name	ORIGINCLEAR, INC.
Entity Central Index Key	0001419793
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Type	10-Q
Document Period End Date	Sep. 30, 2019
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2019
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	false
Entity Ex Transition Period	false
Entity Common Stock, Shares Outstanding		3,915,744
Entity File Number	333-147980
Entity Interactive Data Current	Yes
Entity Incorporation State Country Code	NV

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2019	Dec. 31, 2018
CURRENT ASSETS
Cash	$ 513,926	$ 609,144
Contracts receivable, less allowance for doubtful accounts of $0 and $6,996 respectively	454,521	309,223
Inventory		13,736
Contract assets	13,289	111,001
Convertible note receivable	113,879	84,900
Other receivable	2,500
Prepaid expenses	40,189	46,584
TOTAL CURRENT ASSETS	1,138,304	1,174,588
NET PROPERTY AND EQUIPMENT	126,407	154,250
OTHER ASSETS
Fair value investment-securities	14,000	22,800
Trademark	4,467	4,467
Security deposit	3,500	3,500
TOTAL OTHER ASSETS	21,967	30,767
TOTAL ASSETS	1,286,678	1,359,605
Current Liabilities
Accounts payable and other payable	813,815	987,524
Accrued expenses	1,205,685	1,152,982
Cumulative preferred stock dividends payable	74,982	25,085
Contract liabilities	318,151	112,894
Capital lease, current portion	9,088	9,088
Deferred Income	71,917
Customer deposit	113,950	120,688
Warranty reserve	20,000	20,000
Loan payable, merchant cash advance, net of finance fees of $12,566 and $123,458 respectively	501,615	473,507
Loan payable, related party	206,577	219,841
Promissory note, current portion		110
Derivative liabilities	13,615,889	9,360,204
Convertible promissory notes, net of discount of $0 and $146,005, respectively	2,911,944	1,580,955
Total Current Liabilities	19,863,613	14,062,878
Long Term Liabilities
Capital lease, long term portion	19,345	26,918
Promissory note, long term portion		74,867
Convertible promissory notes, net of discount of $0 and $0, respectively	726,949	2,076,472
Total Long Term Liabilities	746,294	2,178,257
Total Liabilities	20,609,907	16,241,135
COMMITMENTS AND CONTINGENCIES (See Note 11)
SHAREHOLDERS' DEFICIT
Preferred stock value
Common stock, $0.0001 par value, 16,000,000,000 shares authorized 3,099,451 and 875,244 equity shares issued and outstanding, respectively	310	88
Preferred treasury stock,1,000 and 1,000 shares outstanding, respectively
Additional paid in capital	64,528,061	63,179,433
Accumulated other comprehensive loss	(133)	(134)
Accumulated deficit	(88,126,021)	(79,807,981)
TOTAL SHAREHOLDERS' DEFICIT	(23,593,719)	(16,624,530)
TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT	1,286,678	1,359,605
Series F Convertible Preferred Stock
Long Term Liabilities
Convertible Preferred Stock, redeemable value	1,678,000	1,743,000
Series G Convertible Preferred Stock
Long Term Liabilities
Convertible Preferred Stock, redeemable value	530,000
Series I / J Preferred Stock
Long Term Liabilities
Convertible Preferred Stock, redeemable value	797,400
Series K / L Preferred Stock
Long Term Liabilities
Convertible Preferred Stock, redeemable value	1,265,090
Series C
SHAREHOLDERS' DEFICIT
Preferred stock value
Series D-1
SHAREHOLDERS' DEFICIT
Preferred stock value	3,850	3,850
Series E
SHAREHOLDERS' DEFICIT
Preferred stock value	$ 214	$ 214

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)	Sep. 30, 2019	Dec. 31, 2018
Allowance for doubtful accounts	$ 0	$ 6,996
Merchant cash advances, net of finance fees	12,566	123,458
Net of discount, current	0	146,005
Net of discount, non current	$ 0	$ 0
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	550,000,000	550,000,000
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	16,000,000,000	16,000,000,000
Common stock, shares issued	3,099,451	875,244
Common stock, shares outstanding	3,099,451	875,244
Preferred treasury stock, shares outstanding	1,000	1,000
Series F Convertible Preferred Stock
Preferred Stock, shares issued	1,678	1,743
Preferred Stock, shares outstanding	1,678	1,743
Convertible preferred stock, redeemable value	$ 1,678,000	$ 1,743,000
Series G Convertible Preferred Stock
Preferred Stock, shares issued	530	530
Preferred Stock, shares outstanding	530	530
Convertible preferred stock, redeemable value	$ 530,000	$ 0
Series C
Preferred stock, shares issued	1,000	1,000
Preferred stock, shares outstanding	1,000	1,000
Series D-1
Preferred stock, shares issued	38,500,000	38,500,000
Preferred stock, shares outstanding	38,500,000	38,500,000
Series E
Preferred stock, shares issued	2,139,649	2,139,649
Preferred stock, shares outstanding	2,139,649	2,139,649
Series I / J Preferred Stock [Member]
Preferred Stock, shares issued	1,196	1,196
Preferred Stock, shares outstanding	1,196	1,196
Convertible preferred stock, redeemable value	$ 797,400	$ 0
Series K / L Preferred Stock [Member]
Preferred Stock, shares issued	1,898	1,898
Preferred Stock, shares outstanding	1,898	1,898
Convertible preferred stock, redeemable value	$ 1,265,090	$ 0

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Income Statement [Abstract]
Sales	$ 939,468	$ 1,094,118	$ 2,696,433	$ 3,678,261
Cost of Goods Sold	858,828	754,214	2,406,139	2,766,244
Gross Profit	80,640	339,904	290,294	912,017
Operating Expenses
Selling and marketing expenses	409,825	470,926	1,247,332	1,336,512
General and administrative expenses	595,181	771,944	1,766,496	2,143,859
Research and development	29,334	49,880	80,094	167,944
Depreciation and amortization expense	10,955	14,739	32,788	43,857
Total Operating Expenses	1,045,295	1,307,489	3,126,710	3,692,172
Loss from Operations	(964,655)	(967,585)	(2,836,416)	(2,780,155)
OTHER INCOME (EXPENSE)
Other income	4,000	2,017	28,980	32,883
Unrealized gain(loss) on investment securities	(4,400)	200	(8,800)	(13,600)
Realized loss on investment				(20,000)
Loss on sale of asset		(20,000)		(406)
Loss on settlement of convertible notes	33,298		(308,587)
Commitment fee	(70,624)	(41,498)	(238,959)	(425,824)
Gain (Loss) on conversion of debt	472,693	(597,090)	(254,584)	(860,880)
Gain on net change in derivative liability and conversion of debt	(610,682)	7,680,163	(4,275,963)	(60,952)
Interest expense	(80,505)	(737,319)	(423,711)	(1,193,793)
TOTAL OTHER (EXPENSE) INCOME	(256,220)	6,286,473	(5,481,624)	(2,542,572)
NET INCOME (LOSS)	(1,220,875)	5,318,888	(8,318,040)	(5,322,727)
PREFERRED STOCK DIVIDENDS	(74,627)	(1,976)	(194,510)	(1,976)
NET LOSS AVAILABLE TO SHAREHOLDERS	$ (1,295,502)	$ 5,316,912	$ (8,512,550)	$ (5,324,703)
BASIC AND DILUTED LOSS PER SHARE ATTRIBUTABLE TO SHAREHOLDERS'	$ (0.54)	$ 42.13	$ (5.11)	$ (61.32)
WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING, BASIC AND DILUTED	2,259,993	126,237	1,626,550	86,797

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Shareholders' Deficit - USD ($)	Preferred stock	Common stock	Additional Paid-in Capital	Accumulated Other Comprehensive loss	Accumulated Deficit	Total
Balance at Dec. 31, 2017	$ 1	$ 6	$ 58,629,843	$ (134)	$ (68,461,412)	$ (9,831,696)
Balance, shares at Dec. 31, 2017	4,333	56,444
Common stock issuance for conversion of debt			193,309			193,309
Common stock issuance for conversion of debt, shares		3,721
Common stock issued at fair value for services		$ 1	402,511			402,512
Common stock issued at fair value for services, shares		7,628
Stock compensation cost			13,032			13,032
Net Income (loss)					(12,888,316)	(12,888,316)
Balance at Mar. 31, 2018	$ 1	$ 7	59,238,695	(134)	(81,349,728)	(22,111,159)
Balance, shares at Mar. 31, 2018	4,333	67,793
Balance at Dec. 31, 2017	$ 1	$ 6	58,629,843	(134)	(68,461,412)	(9,831,696)
Balance, shares at Dec. 31, 2017	4,333	56,444
Net Income (loss)						(5,322,727)
Balance at Sep. 30, 2018	$ 3,095	$ 35	61,613,155	(134)	(73,784,139)	(12,167,988)
Balance, shares at Sep. 30, 2018	30,945,204	345,426
Balance at Mar. 31, 2018	$ 1	$ 7	$ 59,238,695	$ (134)	$ (81,349,728)	$ (22,111,159)
Balance, shares at Mar. 31, 2018	4,333	67,793
Common stock issuance for conversion of debt
Common stock issuance for conversion of debt, shares		2,876	189,224			189,224
Common stock issued at fair value for services		$ 1	$ 350,401			$ 350,402
Common stock issued at fair value for services, shares		5,598
Series D-1 Preferred stock issued through a private placement	$ 1,581		278,419			280,000
Series D-1 Preferred stock issued through a private placement, shares	15,805,554
Stock compensation cost
Net Income (loss)					2,242,386	2,242,386
Balance at Jun. 30, 2018	$ 1,582	$ 8	60,056,739	(134)	(79,107,342)	(19,049,147)
Balance, shares at Jun. 30, 2018	15,809,887	76,267
Common stock issuance for conversion of debt and accrued interest		$ 14	1,065,715			1,065,729
Common stock issuance for conversion of debt and accrued interest, shares		139,890
Common stock issued at fair value for services		$ 5	241,770			241,775
Common stock issued at fair value for services, shares		45,636
Series F Preferred stock		$ 8	(8)			0
Series F Preferred stock, shares		83,633
Series D Preferred stock converted to Series E Preferred stock	$ (1,581)		(278,419)			(280,000)
Series D Preferred stock converted to Series E Preferred stock, shares	(15,805,554)
Series D-1 Preferred stock issued for services	$ 2,850		(2,850)
Series D-1 Preferred stock issued for services, shares	28,500,000
Series E Preferred stock issued through a private placement	$ 244		506,854			507,098
Series E Preferred stock issued through a private placement, shares	2,440,871
Stock compensation cost			25,330			25,330
Cumulative preferred stock dividend			(1,976)			(1,976)
Net Income (loss)					5,323,203	5,318,888
Balance at Sep. 30, 2018	$ 3,095	$ 35	61,613,155	(134)	(73,784,139)	(12,167,988)
Balance, shares at Sep. 30, 2018	30,945,204	345,426
Balance at Dec. 31, 2018	$ 4,064	$ 88	63,179,433	(134)	(79,807,981)	(16,624,530)
Balance, shares at Dec. 31, 2018	40,640,649	875,244
Common stock issuance for conversion of debt and accrued interest		$ 31	891,224			891,255
Common stock issuance for conversion of debt and accrued interest, shares		313,014
Common stock issued at fair value for services		$ 11	279,218			279,229
Common stock issued at fair value for services, shares		116,539
Common stock issued through a private placement for purchase of Series G Preferred stock		$ 8	(8)
Common stock issued through a private placement for purchase of Series G Preferred stock, shares		82,799
Cumulative preferred stock dividend			(38,156)			(38,156)
Other comprehensive gain				1		1
Net Income (loss)					(331,272)	(331,272)
Balance at Mar. 31, 2019	$ 4,064	$ 138	64,311,711	(133)	(80,139,253)	(15,823,473)
Balance, shares at Mar. 31, 2019	40,640,649	1,387,596
Balance at Dec. 31, 2018	$ 4,064	$ 88	63,179,433	(134)	(79,807,981)	(16,624,530)
Balance, shares at Dec. 31, 2018	40,640,649	875,244
Net Income (loss)						(8,318,040)
Balance at Sep. 30, 2019	$ 4,064	$ 310	64,528,061	(133)	(88,126,021)	(23,593,719)
Balance, shares at Sep. 30, 2019	40,640,649	3,099,451
Balance at Mar. 31, 2019	$ 4,064	$ 138	64,311,711	(133)	(80,139,253)	(15,823,473)
Balance, shares at Mar. 31, 2019	40,640,649	1,387,596
Common stock issuance for conversion of debt and accrued interest		$ 33	380,713			380,746
Common stock issuance for conversion of debt and accrued interest, shares		329,600
Common stock issued at fair value for services		$ 10	104,095			104,105
Common stock issued at fair value for services, shares		96,464
Cumulative preferred stock dividend			(54,713)			(54,713)
Net Income (loss)					(6,765,893)	(6,765,893)
Balance at Jun. 30, 2019	$ 4,064	$ 181	64,741,806	(133)	(86,905,146)	(22,159,228)
Balance, shares at Jun. 30, 2019	40,640,649	1,813,660
Common stock issuance for conversion of debt and accrued interest		$ 75	395,204			395,279
Common stock issuance for conversion of debt and accrued interest, shares		753,939
Common stock issued at fair value for services		$ 53	239,754			239,807
Common stock issued at fair value for services, shares		531,330
Common stock reverse split share adjustment		$ 1	(1)
Common stock reverse split share adjustment, shares		522
Cumulative preferred stock dividend			(74,627)			(74,627)
Gain on conversion of debt			(774,075)			(774,075)
Net Income (loss)					(1,220,875)	(1,220,875)
Balance at Sep. 30, 2019	$ 4,064	$ 310	$ 64,528,061	$ (133)	$ (88,126,021)	$ (23,593,719)
Balance, shares at Sep. 30, 2019	40,640,649	3,099,451

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (8,318,040)	$ (5,322,727)
Adjustment to reconcile net loss to net cash used in operating activities
Depreciation and amortization	32,788	43,857
Common stock and warrants issued for services	623,141	994,689
Stock option and warrant compensation expense		38,362
(Gain) Loss on net change in valuation of derivative liability	4,275,963	60,952
Loss on conversion of debt	254,585	860,880
Loss on settlement of debt	308,587
Debt discount recognized as interest expense	146,005	483,577
Loss on sale of asset		406
Net unrealized loss on fair value of security	8,800	13,600
Realized loss on security investment		20,000
Exchange of investment for services		80,000
Amortization of financing cost	135,358	246,035
Change in Assets (Increase) Decrease in:
Contracts receivable	(145,298)	75,504
Contract asset	97,712	51,828
Inventory asset	13,736	(123)
Prepaid expenses and other assets	6,395	27,521
Other assets	(2,500)
Change in Liabilities Increase (Decrease) in:
Accounts payable	(173,708)	(151,264)
Accrued expenses	30,423	320,233
Contract liabilities	205,257	96,136
Customer deposit	(6,738)
Deferred income	71,917	49,500
NET CASH (USED IN) PROVIDED BY OPERATING ACTIVITIES	(2,435,617)	(2,011,034)
CASH FLOWS USED FROM INVESTING ACTIVITIES:
Fair value investment - security		(100,000)
Convertible note receivable	(28,979)	(80,000)
Proceeds from sale of asset		2,000
Purchase of fixed assets	(4,945)	(17,357)
CASH USED IN INVESTING ACTIVITIES	(33,924)	(195,357)
CASH FLOWS FROM FINANCING ACTIVITIES:
Payments on capital lease	(7,573)	(7,162)
Loan payable, truck		(15,699)
Loan payable, financing		1,366,246
Payments on loan payable, financing	(107,250)	(987,471)
Payments on loan payable, related party	(13,264)	248,870
Promissory note payable, related party		67,500
Payments on promissory note payable, related party	(74,977)	(13,626)
Net cumulative preferred stock dividends payable	49,897
Proceeds from convertible promissory notes		750,500
Payment on redemption of preferred stock	(65,000)
Net Proceeds for issuance of preferred and common stock for cash	2,592,490	1,257,098
NET CASH PROVIDED BY FINANCING ACTIVITIES	2,374,323	2,666,256
NET (DECREASE) INCREASE IN CASH	(95,218)	459,865
CASH BEGINNING OF PERIOD	609,144	439,822
CASH END OF PERIOD	513,926	899,687
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Interest paid	16,926	212,284
Taxes paid
SUPPLEMENTAL DISCLOSURES OF NON CASH TRANSACTIONS
Common stock issued at fair value for conversion of debt and accrued interest	893,202	1,448,262
Common stock issued at fair value for supplemental shares		424,245
Capitalized leased asset		45,440
Settlement of derivative	1,176,961
Stock issued on private placement	$ 8

Organization and Line of Busine

Organization and Line of Business	9 Months Ended
	Sep. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION AND LINE OF BUSINESS	1. The accompanying unaudited condensed consolidated financial statements of OriginClear, Inc. (the "Company") have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all normal recurring adjustments considered necessary for a fair presentation have been included. Operating results for the nine months ended September 30, 2019 are not necessarily indicative of the results that may be expected for the year ending December 31, 2019. For further information refer to the financial statements and footnotes thereto included in the Company's Form 10-K for the year ended December 31, 2018. Going Concern The accompanying unaudited condensed consolidated financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and liabilities and commitments in the normal course of business. The accompanying unaudited condensed consolidated financial statements do not reflect any adjustments that might result if the Company is unable to continue as a going concern. The Company's revenue is not yet sufficient to cover its operating expenditures and the Company has negative cash flows from operations, which raise substantial doubt about the Company's ability to continue as a going concern. The ability of the Company to continue as a going concern and appropriateness of using the going concern basis is dependent upon, among other things, raising additional capital and increasing sales. Management believes the existing shareholders, prospective new investors, current and future sales will provide the additional cash needed to meet the Company's obligations as they become due, and will allow the development of its core business operations. No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, it may contain restrictions on our operations, in the case of debt financing, or cause substantial dilution for our stockholders, in case of equity financing.

Summary of Significant Accounti

Summary of Significant Accounting Polices	9 Months Ended
	Sep. 30, 2019
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICES	2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICES This summary of significant accounting policies of the Company is presented to assist in understanding the Company’s unaudited condensed consolidated financial statements. The unaudited condensed consolidated financial statements and notes are representations of the Company’s management, which is responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the unaudited condensed consolidated financial statements. Principles of Consolidation The accompanying unaudited condensed consolidated financial statements include the accounts of OriginClear, Inc. and its wholly owned operating subsidiaries, Progressive Water Treatment, Inc., and OriginClear Technology Limited. All material intercompany transactions have been eliminated upon consolidation of these entities. Loss per Share Calculations Basic loss per share calculations are computed by dividing income (loss) available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed similar to basic earnings per share except that the denominator is increased to include securities or other contracts to issue common stock that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. Nine months ended September 30, 2019 The Company has excluded 122,044 shares of common stock issuable pursuant to outstanding warrants, shares of common stock issuable pursuant to outstanding convertible debt of $3,638,893, and shares issuable upon conversion of convertible preferred stock for the three and nine months ended September 30, 2019, because their impact on the loss per share is anti-dilutive. Nine Months Ended September 30, 2018 The Company has excluded 1,80582, stock options, 130,575 warrants, convertible debt of $3,494,546 and shares issuable upon conversion of convertible preferred stock for the nine months ended September 30, 2018, because their impact on the loss per share is anti-dilutive. The Company did include convertible debt of $549,308 in its diluted earnings per share, because their impact on the earnings per share is dilutive. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include estimates used to review the Company’s impairments and estimations of long-lived assets, revenue recognition on percentage of completion type contracts, allowances for uncollectible accounts, warranty reserves, inventory valuation, debt beneficial conversion features, fair value investments, valuations of non-cash capital stock issuances and the valuation allowance on deferred tax assets. The Company bases its estimates on historical experience and on various other assumptions the Company believes to be reasonable in the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. Stock-Based Compensation The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by the Financial Accounting Standards Board whereas the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option and warrant grants issued and vesting to non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option grants are immediately vested and the total stock-based compensation charge is recorded in the period of the measurement date. Revenue Recognition We recognize revenue when services are performed, and at the time of shipment of products, provided that evidence of an arrangement exists, title and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured. Revenues and related costs on construction contracts are recognized as the performance obligations for work are satisfied over time in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers. Under ASC 606, revenue and associated profit, will be recognized as the customer obtains control of the goods and services promised in the contract (i.e., performance obligations). All un-allocable indirect costs and corporate general and administrative costs are charged to the periods as incurred. However, in the event a loss on a contract is foreseen, the Company will recognize the loss as it is determined. Revisions in cost and profit estimates during the course of the contract are reflected in the accounting period in which the facts for the revisions become known. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions, and estimated profitability, including those arising from contract penalty provisions, and final contract settlements, may result in revisions to costs and income, which are recognized in the period the revisions are determined. Contract receivables are recorded on contracts for amounts currently due based upon progress billings, as well as retention, which are collectible upon completion of the contracts. Accounts payable to material suppliers and subcontractors are recorded for amounts currently due based upon work completed or materials received, as are retention due subcontractors, which are payable upon completion of the contract. General and administrative expenses are charged to operations as incurred and are not allocated to contract costs. Contract Receivable The Company bills its customers in accordance with contractual agreements. The agreements generally require billing to be on a progressive basis as work is completed. Credit is extended based on evaluation of clients’ financial condition and collateral is not required. The Company maintains an allowance for doubtful accounts for estimated losses that may arise if any customer is unable to make required payments. Management performs a quantitative and qualitative review of the receivables past due from customers on a monthly basis. The Company records an allowance against uncollectible items for each customer after all reasonable means of collection have been exhausted, and the potential for recovery is considered remote. The allowance for doubtful accounts were $0 as of September 30, 2019 and $6,996 as of December 31, 2018. The net contract receivable balance was $454,521 and $309,223 at September 30, 2019 and December 31, 2018, respectively. Fair Value of Financial Instruments Fair Value of Financial Instruments, requires disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of September 30, 2019, the balances reported for cash, contract receivables, contract assets, prepaid expenses, accounts payable, contract liabilities, and accrued expenses, and derivative instruments approximate the fair value because of their short maturities. We adopted ASC Topic 820 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The following table presents certain investments and liabilities of the Company’s financial assets and liabilities measured and recorded at fair value on the Company’s balance sheets on a recurring basis and their level within the fair value hierarchy as of September 30, 2019. Total (Level 1) (Level 2) (Level 3) Investment at fair value-securities $ 14,000 $ 14,000 $ - $ - Total Assets measured at fair value $ 14,000 $ 14,000 $ - $ - Total (Level 1) (Level 2) (Level 3) Derivative Liability $ 13,615,889 $ - $ - $ 13,615,889 Total liabilities measured at fair value $ 13,615,889 $ - $ - $ 13,615,889 The following is a reconciliation of the derivative liability for which level 3 inputs were used in determining the approximate fair value: Balance as of January 1, 2019 $ 9,360,204 Fair Value of derivative liabilities issued - Loss on net change in derivative liability 4,255,685 Balance as of September 30, 2019 $ 13,615,889 Segment Reporting The Company’s business currently operates in one segment based upon the Company’s organizational structure and the way in which the operations are managed and evaluated. Marketable Securities The Company adopted ASU 2016-01, “Financial Instruments – Recognition and Measurement of Financial Assets and Financial Liabilities.” ASU 2016-01 requires investments (except those accounted for under the equity method of accounting, or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income. It requires public business entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purpose, and separate presentation of financial assets and financial liabilities by measurement category and form of financial asset. It eliminates the requirement for public business entities to disclose the method(s) and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost. The Company has evaluated the potential impact this standard may have on the condensed consolidated financial statements and determined that it had a significant impact on the condensed consolidated financial statements. The Company accounts for its investment in Water Technologies International, Inc. as available-for-sale securities, and the unrealized gain on the available-for-sale securities is recognized in net income. Licensing agreement The Company analyzed the licensing agreement using ASU 606 to determine the timing of revenue recognition. The licensing of the intellectual property (IP) is distinct from the non-license goods or services and has significant standalone functionality that provides a benefit or value. The functionality will not change during the license period due to the licensor’s activities. Because the significant standalone functionality is delivered immediately, the revenue is generally recognized when the license is delivered. Recently Issued Accounting Pronouncements In February 2016, the FASB established ASC Topic 842, Leases (Topic 842), by issuing ASU No. 2016-02, which requires lessees to recognize leases on-balance sheet and disclose key information about leasing arrangements. Topic 842 was subsequently amended by ASU No. 2018-01, Land Easement Practical Expedient for Transition to Topic 842; ASU No. 2018-10, Codification Improvements to Topic 842, Leases; and ASU No. 2018-11, Targeted Improvements. The new standard establishes a right-of-use (ROU) model that requires a lessee to recognize a ROU asset and lease liability on the balance sheet. Leases will be classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the statement of operations. The Company adopted the new standard on January 1, 2019. The new standard provides a number of optional practical expedients in transition. The Company has elected the ‘package of practical expedients’, which permit it not to reassess under the new standard its prior conclusions about lease identification, lease classification and initial direct costs. The Company did not elect the use-of-hindsight or the practical expedient pertaining to land easements; the latter is not applicable to the Company. The new standard did not have a material impact on the Company’s unaudited condensed consolidated financial statements. In August 2017, FASB issued accounting standards update ASU-2017-12, “D” (Topic 815) – “Targeted Improvements to Accounting for Hedging Activities”, to require an entity to present the earnings effect of the hedging instrument in the same statement line item in which the earnings effect of the hedged item is reported. The amendments in this update are effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods with the fiscal years beginning after December 15, 2020. Early adoption is permitted in any interim period after issuance of the update. The Company has evaluated the impact of the adoption of ASU 2017-12 on the Company’s unaudited condensed consolidated financial statements, which had no material impact. In June 2018, FASB issued accounting standards update ASU 2018-07, (Topic 505) – “Shared-Based Payment Arrangements with Nonemployees”, which simplifies the accounting for share-based payments granted to nonemployees for goods and services. Under the ASU, most of the guidance on such payments to nonemployees will be aligned with the requirements for share-based payments granted to employees. Under the ASU 2018-07, the measurement of equity-classified nonemployee share-based payments will be fixed on the grant date, as defined in ASC 718, and will use the term nonemployee vesting period, rather than requisite service period. The amendments in this update are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early adoption is permitted if financial statements have not yet been issued. The Company adopted ASU 2018-07 on the January 1, 2019. The adoption of the new standard did not have a material impact on the Company’s unaudited condensed consolidated financial statements. Management reviewed currently issued pronouncements and does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying unaudited condensed consolidated financial statements. Reclassification of Expenses During the nine months ended September 30, 2019, certain expenses were reclassified in the financial statements, which had no material effect.

Capital Stock

Capital Stock	9 Months Ended
	Sep. 30, 2019
Equity [Abstract]
CAPITAL STOCK	3. CAPITAL STOCK Preferred Stock On April 13, 2018, the Company filed a certificate of amendment to its articles of incorporation to increase its authorized shares of preferred stock, par value $0.0001 per share to 550,000,000 shares from 750,000 shares. Series C On March 14, 2017, the Board of Directors authorized the issuance of 1,000 shares of Series C preferred stock to T. Riggs Eckelberry in exchange for his continued employment with the Company. The purchase price of the Series C preferred stock was $0.0001 per share representing a total purchase price of $0.10 for 1,000 shares. Series D On April 13, 2018, the Company filed a Certificate of Designation of Series D preferred stock (the “Series D preferred stock”) with the Secretary of State of Nevada, designating 400,000,000 shares of its authorized preferred stock as 0% Series D preferred stock, with a par value of $0.0001 per share. The shares of Series D preferred stock did not have a dividend rate or liquidation preference and did not carry any voting rights. As of August 14, 2018, the Series D preferred stock were cancelled, and exchanged for Series E preferred shares. Series D-1 On April 13, 2018, the Company filed a Certificate of Designation for its Series D-1 Convertible preferred stock (the “Series D-1 preferred stock”) with the Secretary of State of Nevada designating 50,000,000 shares of its authorized preferred stock as Series D-1 preferred stock, with a par value of $0.0001 per share. The shares of Series D-1 preferred stock do not have a dividend rate or liquidation preference. Each share of Series D-1 preferred stock is convertible into one share of common stock, adjusted for any stock splits with respect to the shares. The shares of Series D-1 preferred stock do not carry any voting rights. At no time may all or a portion of the Series D-1 preferred stock be converted if the number of shares of common stock to be issued pursuant to such conversion would exceed, when aggregated with all other shares of common stock owned by the holder at such time, the number of shares of common stock that would result in the holder beneficially owning more than 4.99% of all of the common stock outstanding at such time, which amount may be increased to 9.99% at the holder’s discretion upon 61 days written notice. The Company issued an aggregate of 38,500,000 Series D-1 preferred shares for services. As of September 30, 2019, there were 38,500,000 Series D-1 preferred shares issued and outstanding. Series E On August 14, 2018, the Company filed a Certificate of Designation for its 0% Series E Convertible preferred stock (the “Series E preferred stock”) with the Secretary of State of Nevada designating 4,000,000 shares of its authorized preferred stock as Series E preferred stock. The shares of Series E preferred stock have a par value of $0.0001 per share. The shares of Series E preferred stock do not have a dividend rate or liquidation preference. Each share of Series E preferred stock is convertible into a number of shares of common stock equal to the greater of (A) 100 shares of common stock and (B) the number of shares of common stock the holder would have received pursuant to such holder’s respective subscription agreement if the preferred shares were priced based on the average closing sale price of the common stock during the three trading days prior to the date the holder requests a conversion, provided the lowest price for which an adjustment will be made is 50% of the purchase price paid by any purchase of the Series E preferred stock, adjusted for any stock splits with respect to the shares. The shares of Series E preferred stock do not carry any voting rights. At no time may all or a portion of the Series E preferred stock be converted if the number of shares of common stock to be issued pursuant to such conversion would exceed, when aggregated with all other shares of common stock owned by the holder at such time, the number of shares of common stock that would result in the holder beneficially owning more than 4.99% of all of the common stock outstanding at such time, which amount may be increased to 9.99% at the holders discretion upon 61 days written notice. As of September 30, 2019, there were 2,139,649 shares of Series E preferred stock issued and outstanding. In connection with the issuance of the Series E preferred stock, the Company also issued one hundred warrants to purchase shares of common stock for each share of Series E preferred stock. Series F On August 14, 2018, the Company filed a Certificate of Designation for its Series F Convertible preferred stock (the “Series F preferred stock”) with the Secretary of State of Nevada designating 6,000 shares of Series F Preferred Stock. The shares of Series F preferred stock have a par value of $0.0001 per share. The shares of Series F preferred stock have a liquidation preference of stated value per share of $1,000 per share plus any accrued but unpaid dividends thereon before any distribution or payment may be made to the holders of any common stock or any other series of capital stock then-existing or thereinafter created. The stated value of Series F preferred stock is $1,000 per share and holders of Series F preferred stock are entitled to cumulative dividends at the annual rate of 8% of the stated value, payable quarterly. The shares of Series F preferred stock do not carry any voting rights. The Company may, in its sole discretion, at any time while the Series F preferred stock is outstanding, redeem all or any portion of the outstanding Series preferred stock at a price equal to the stated value, plus any accrued but unpaid dividends. The Company may exercise such redemption right by providing a minimum of 5 days written notice of such redemption to the Holders. In the event the Company exercises such redemption right for less than all of the then-outstanding shares of Series F preferred stock, the Company shall redeem the outstanding shares of the Holders of a pro-rata basis. The Series F is mandatorily redeemable on September 1, 2020. The Series F Preferred Stock is not convertible into common stock. As of September 30, 2019, the Company accrued dividends in the amount of $33,560. As of September 30, 2019, there were 1,678 shares of Series F preferred stock issued and outstanding. Series G On January 16, 2019, the Company filed a Series G Certificate of Designation with the Nevada Secretary of State (the “Series G Designation”). Pursuant to the Series G Certificate of Designation, the Company may issue up to 6,000 shares of Series G preferred stock, each share having a stated value of $1,000 per share and holders of Series G preferred stock are entitled to cumulative dividends at the annual rate of 8% of the stated value, payable quarterly. Pursuant to certain subscription agreements entered into with purchasers of the Series G preferred stock, each purchaser shall receive shares of the Company’s common stock equal to an amount of, for each share of Series G preferred stock purchased, five hundred dollars ($500) divided by the closing price on the date the Company receives the executed subscription documents and purchase price from such investor. Between January 16, 2019 and March 20, 2019, the Company entered into subscription agreements with certain accredited investors pursuant to which the Company sold an aggregate of 530 shares of the Company’s Series G preferred stock for an aggregate purchase price of $530,000. As of September 30, 2019, the Company issued an aggregate of 82,799 shares of its common stock to certain holders of its Series G preferred stock. As of September 30, 2019, the Company accrued dividends in the amount of $10,600. Series I / J On April 3, 2019, the Company filed a Series I Certificate of Designation (the “Series I COD”) for its Series I Preferred Stock (the “Series I”) and a Series J Certificate of designation (the “Series J COD”) for its Series J Preferred Stock (the “Series J”) with the Nevada Secretary of State. Pursuant to the Series I COD, the Company designated 4,000 shares of preferred stock as Series I. The Series I has a stated value of $1,000 per share. Series I holders are entitled to cumulative dividends at the annual rate of 8% of the stated value, payable quarterly within 60 days from the end of each fiscal quarter. The Series I will not be entitled to any voting rights except as may be required by applicable law, and will not be convertible into common stock. The Company will have the right to redeem the Series I at any time while the Series I are outstanding at a price equal to the stated value plus any accrued but unpaid dividends. The Company will be required to redeem the Series I two years following the date that is the later of the (i) final closing of the tranche (as designated in the applicable subscription agreement) or (ii) the expiration date of the tranche that such shares to be redeemed were a part of. Pursuant to the Series J COD, the Company designated 100,000 shares of preferred stock as Series J. The Series J has a stated value of $1,000 per share and holders will be entitled to receive dividends on an as-converted basis with the Company’s common stock. The Series J preferred stock is convertible into shares of the Company’s common stock, on the terms and conditions set forth in the Series J COD, which includes certain Make-Good Shares for certain holders of the Company’s previously disclosed Series F preferred stock and Series G preferred stock. As of September 30, 2019, the Company issued an aggregate of 797.4 shares of its Series I preferred stock and 398.7 shares of its Series J preferred stock. As of September 30, 2019, the Company accrued dividends in the amount of $15,948. Series K / L On June 3, 2019, the Company executed a Series K Certificate of Designation (the “Series K COD”) for its Series K Preferred Stock (the “Series K”) and a Series L Certificate of designation (the “Series L COD”) for its Series L Preferred Stock (the “Series L”). Pursuant to the Series K COD, the Company designated 4,000 shares of preferred stock as Series K. The Series K has a stated value of $1,000 per share. Series K holders are entitled to cumulative dividends at the annual rate of 8% of the stated value, payable quarterly within 60 days from the end of each fiscal quarter. The Series K will not be entitled to any voting rights except as may be required by applicable law, and will not be convertible into common stock. The Company will have the right to redeem the Series K at any time while the Series K are outstanding at a price equal to the stated value plus any accrued but unpaid dividends. The Company will be required to redeem the Series K two years following the date that is the later of the (i) final closing of the tranche (as designated in the applicable subscription agreement) or (ii) the expiration date of the tranche that such shares to be redeemed were a part of. Pursuant to the Series L COD, the Company designated 100,000 shares of preferred stock as Series L. The Series L has a stated value of $1,000 per share and holders will be entitled to receive dividends on an as-converted basis with the Company’s common stock. The Series L preferred stock is convertible into validly-issued, fully paid and non-assessable shares of the Company’s common stock, on the terms and conditions set forth in the Series L COD, which includes certain Make-Good Shares for certain holders of the Company’s previously disclosed investment rounds. As of September 30, 2019, the Company issued an aggregate of 1,265.15 shares of its Series K preferred stock and 632.58 shares of its Series L preferred stock. As of September 30, 2019, the Company accrued dividends in the amount of $14,519. Common Stock On April 23, 2019, the Company filed a Certificate of Amendment to its Articles of Incorporation, with the Secretary of State of the State of Nevada to effectuate an increase to the number of authorized shares of common stock of the Company from 8,000,000,000 to 16,000,000,000. Effective October 25, 2019, the Company filed a certificate of amendment to its articles of incorporation, with the State of Nevada effectuating a reverse split of the Company’s common stock at a ratio of 1 for 2,000. The Company added 522 shares to outstanding common stock for the adjustment of the reverse split. Nine months ended September 30, 2019 The Company issued 1,396,552 shares of common stock upon conversion of convertible promissory notes in an aggregate principal amount of $460,135, and a default settlement of $77,924, plus interest in the amount of $100,557, with an aggregate fair value loss on conversion of debt in the amount of $254,585, based upon conversion prices of $0.40 to $3.60. The Company issued 744,333 shares of common stock for services at fair value of $623,141 at prices ranging from $0.40 to $0.60 per share. The Company issued 82,799 shares of common stock in conjunction with the issuance of Series G preferred stock, through a private placement at par value. Nine months ended September 30, 2018 The Company issued 6,597 shares of common stock upon conversion of convertible promissory notes in an aggregate principal in the amount of $88,000, plus interest in the amount of $30,743, with an aggregate fair value loss on conversion of debt in the amount of $263,790, based upon conversion prices of $38.00 to $65.80. The Company issued 13,226 shares of common stock for services at fair value of $752,914.

Convertible Promissory Notes

Convertible Promissory Notes	9 Months Ended
	Sep. 30, 2019
Debt Disclosure [Abstract]
CONVERTIBLE PROMISSORY NOTES	4. CONVERTIBLE PROMISSORY NOTES As of September 30, 2019, the outstanding convertible promissory notes are summarized as follows: Convertible Promissory Notes $ 3,638,893 Less current portion 2,911,944 Total long-term liabilities $ 726,949 Maturities of long-term debt for the next five years are as follows: Period Ending September 30, 2019 Amount 2020 2,911,944 2021 125,000 2022 - 2023 73,128 2024 528,821 $ 3,638,893 The remaining balance of convertible promissory notes as of September 30, 2019 was $3,638,893. On various dates, the Company issued unsecured convertible promissory notes (the “Notes”), that matured during the period and were extended sixty (60) days from the effective date of each Note. The Notes bear interest at 10% per annum. The Notes may be converted into shares of the Company’s common stock at conversion prices ranging from the lesser of $4,200 to $9,800 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the Notes. In addition, for as long as the Notes or other convertible notes in effect between the purchaser and the Company are outstanding, if the Company issues any security with terms more favorable than the terms of the Notes or such other convertible notes or a term was not similarly provided to the purchaser of the Notes or such other convertible notes, then such more favorable or additional term shall, at the purchaser’s option, become part of the Notes and such other convertible notes. The conversion feature of the Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Notes. During the nine months ended September 30, 2019, the Company issued 584,184 shares of common stock, upon conversion of $165,300 in principal, plus accrued interest of $74,284, with a fair value loss on settlement of $407,649. As of September 30, 2019, the Notes had an aggregate remaining balance of $1,114,000. As of December 31, 2018, the unsecured convertible promissory notes (the “OID Notes”) had an aggregate remaining principal balance of $143,228. The OID Notes included an original issue discount and one time interest, which has been fully amortized. The OID Notes matured on June 30, 2018, and were extended through June 30, 2023. The OID Notes were convertible into shares of the Company’s common stock at a conversion price initially of $30,620. After the amendment, the conversion price changed to the lesser of $5,600 per share, or b) fifty percent (50%) of the lowest trade price of common stock recorded since the original effective date of this note, or c) the lowest effective price per share granted to any person or entity after the effective date. The conversion feature of the notes was considered a derivative in accordance with current accounting guidelines, because of the reset conversion features of the notes. During the nine months ended September 30, 2019, the Company issued 70,111 shares of common stock upon conversion of $70,100 in principal, with a fair value loss on conversion of debt in the amount of $126,144. As of September 30, 2019, the remaining balance on the note was $73,128. The Company issued various, unsecured convertible promissory notes (the “2015-2016 Notes”), on various dates ending on May 19, 2016. The 2015-2016 Notes matured and were extended from the date of each tranche through maturity dates ending on May 19, 2020. The 2015-2016 Notes bear interest at 10% per annum. The 2015-2016 Notes may be converted into shares of the Company’s common stock at conversion prices ranging from the lesser of $1,400.00 to $5,600 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the 2015-2016 Notes. The conversion feature of the 2015-2016 Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the 2015-2016 Notes. The remaining balance of the 2015-2016 Notes as of September 30, 2019, was $1,325,000. The Company issued a convertible note (the “Dec 2015 Note”) in exchange for an accounts payable in the amount of $432,048, which could be converted into shares of the Company’s common stock after December 31, 2015. The Dec 2015 Note was accounted for under ASC 470, whereby, a beneficial conversion feature was recorded at time of issuance. The Dec 2015 Note did not meet the criteria of a derivative, and was accounted for as a beneficial conversion feature, which was amortized over the life of the Dec 2015 Note and recognized as interest expense in the financial statements. On January 1, 2016, the Dec 2015 Note met the criteria of a derivative and was accounted for under ASC 815. The Dec 2015 Note has zero stated interest rate, and the conversion price shall be equal to 75% of the average three lowest last sale prices traded during the 25 trading days immediately prior to conversion. As of September 30, 2019, the remaining balance on the Dec 2015 Note was $167,048. The Company issued a convertible note (the “Sep 2016 Note”) in exchange for an accounts payable in the amount of $430,896, which could be converted into shares of the Company’s common stock after September 15, 2016. The Sep 2016 Note was accounted for under ASC 470, whereby, a beneficial conversion feature was recorded at time of issuance. On September 15, 2016, the Sep 2016 Note met the criteria of a derivative and was accounted for under ASC 815. The Sep 2016 Note has zero stated interest rate, and the conversion price shall be equal to 75% of the average three lowest last sale prices traded during the 25 trading days immediately prior to conversion. The Sep 2016 Note did not meet the criteria of a derivative at the time it was entered into, and was accounted for as a beneficial conversion feature, which was amortized over the life of the Sep 2016 Note and recognized as interest expense in the financial statements. The conversion feature of the Sep 2016 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion feature of the Sep 2016 Note. As of September 30, 2019, the remaining balance on the Sep 2016 Note was $430,896. The Company issued various unsecured convertible promissory notes (the “Jan-Aug 2018 Notes”), in the aggregate amount of $293,000 on various dates from January 24, 2018 thru August 28, 2018. The Jan-Aug 2018 Notes matures on dates from January 24, 2018 thru August 28, 2019. The Jan-Aug 2018 Notes bear interest at 10% per annum. The Jan-Aug 2018 Notes may be converted into shares of the Company’s common stock at a variable conversion price of 61% of the lowest one (1) trading day during the ten (10) trading days prior to conversion. The conversion feature of the Jan-Aug 2018 Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Jan-Aug 2018 Notes. During the nine months ended September 30, 2019, the Company issued 74,014 shares of common stock, upon conversion of principal in the amount of $81,000, plus accrued interest of $5,903, and a loss on settlement of $40,500, with a fair value loss on conversion of debt in the amount of $99,667. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $42,260 during the nine months ended September 30, 2019. As of September 30, 2019, the Jan-Aug 2018 Notes were fully converted. The Company issued two (2) unsecured convertible promissory notes (the “Feb 2018 Notes”), in the aggregate principal amount of $157,500 (each in the amount of $78,750) on February 23, 2018. The Feb 2018 Notes had a maturity date of February 23, 2019, and bear interest at 10% per annum. The first of the two Feb 2018 Notes shall be paid for by the Buyer. The second of the two Feb 2018 Notes shall initially be paid for by the issuance of an offsetting $78,750 secured note issued to the Company by the Buyer. The first of the two notes was funded with cash and the Company must agree to the funding of the second of the two Feb 2018 Notes, before it can be funded with cash. The second of the two Feb 2018 Notes is secured by assets of the Buyer having a fair market value of at least $78,750. The second of the Feb 2018 Notes was issued on August 23, 2018 in the amount of $78,750. The second of the Feb 2018 Notes may be converted into shares of the Company’s common stock at a conversion price of $0.03 or 50% discount of the lowest trading price during the twenty (20) trading days prior to conversion. The conversion feature of the Feb 2018 Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Feb 2018 Notes. During the period ended June 30, 2019, the Company entered into a settlement agreement with the investor in the amount of $20,275 (50% of the outstanding balance of $40,550), based on the outstanding balance due and payable under the Notes. During the nine months ended September 30, 2019, the Company issued 76,665 shares of common stock, upon conversion of principal in the amount of $40,550, plus accrued interest of $5,205, and a settlement loss of $20,275, with a fair value loss on conversion of debt of $152,056. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $50,702 during the nine months ended September 30, 2019. As of September 30, 2019, the Note was fully converted. The Company issued two (2) unsecured convertible promissory notes (the “Apr & May 2018 Notes”), in the aggregate amount of $300,000 on April 2, 2018 and May 31, 2018. The Apr & May 2018 Notes mature on April 2, 2019 and May 31, 2019, respectively. The Apr & May 2018 Notes bear interest at 10% per annum. The Apr & May 2018 Notes may be converted into shares of the Company’s common stock at a variable conversion price of 50% of the lesser of the lowest trading price twenty five (25) trading days prior to conversion. The conversion feature of the Apr & May 2018 Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Notes. During the nine months ended September 30, 2019, the Company issued 12,500 shares of common stock upon conversion of principal in the amount of $6,523, plus accrued interest of $4,727, with a fair value loss on conversion of $16,250. On March 13, 2019, the Company entered into a settlement agreement with the investor in the amount of $570,000, based on the outstanding balance due and payable under the Apr & May 2018 Notes. The Company set up a reserve of 2,630,769 shares of common stock of the Company for issuance upon conversion by the investor of the amounts owed under the Notes, in accordance with the terms of the Notes, including, but no limited to the beneficial ownership limitations contained in the Notes. In addition to the foregoing, upon the sale by the investor of the settlement shares as delivered to the investor by the Company, resulting in total net proceeds less than the settlement value, the investor is entitled to additional settlement shares of the Company’s common stock. If after the investor has sold all settlement shares, the investor delivers a written notice to the Company certifying that the investor is entitled to additional settlement shares of the Company’s common stock (the “Make-Whole Shares”). The number of make-whole shares being equal to the greater of ((i) zero and (ii) the quotient of (1) the difference of (x) the settlement value with respect to each sale of shares by the Investor after the delivery of the Settlement Shares, minus (y) the aggregate net consideration received by the Investor from the resale of all shares of common stock issued by the Company, divided by (2) the average trailing closing price for ten (10) trading days for the shares immediately preceding the date of delivery of the make-whole shares. During the nine months ended September 30,2019, the Company issued 281,788 shares of common stock upon conversion of principal in the amount of $28,185, plus accrued interest of $10,727, with a fair value loss on conversion of debt in the amount of $130,131. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $51,605 during the nine months ended September 30, 2019. As of September 30, 2019, the remaining balance on the Apr & May 2018 Notes were $528,821. The Company issued an unsecured convertible promissory notes (the “Nov 2018 Note”), in the sum amount of $75,000 on November 30, 2018. The Nov 2018 Note matures on November 30, 2019. The Nov 2018 Note bears interest at 10% per annum. The Nov 2018 Note may be converted into shares of the Company’s common stock at a fixed conversion price of $0.05 per share or 50% of the average three (3) lowest trading prices twenty (20) trading days prior to conversion. The conversion feature of the Nov 2018 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Notes. During the nine months ended September 30, 2019, the Company issued 363,229 shares of common stock upon conversion of principal in the amount of $75,000, plus accrued of $4,439, and a settlement loss of $17,150, with a fair value loss on conversion of debt in the amount of $138,078. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $1,438 during the nine months ended September 30, 2019. The Nov 2018 Note was fully converted as of September 30, 2019. We evaluated the financing transactions in accordance with ASC Topic 815, Derivatives and Hedging, and determined that the conversion feature of the convertible promissory notes was not afforded the exemption for conventional convertible instruments due to its variable conversion rate. The note has no explicit limit on the number of shares issuable so they did not meet the conditions set forth in current accounting standards for equity classification. The Company elected to recognize the note under paragraph 815-15-25-4, whereby, there would be a separation into a host contract and derivative instrument. The Company elected to initially and subsequently measure the note in its entirety at fair value, with changes in fair value recognized in earnings. The Company recorded a derivative liability representing the imputed interest associated with the embedded derivative. The derivative liability is adjusted periodically according to the stock price fluctuations. The derivative liability recognized in the financial statements as of September 30, 2019 was $13,615,889.

Derivative Liabilities

Derivative Liabilities	9 Months Ended
	Sep. 30, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]
DERIVATIVE LIABILITIES	5. DERIVATIVE LIABILITIES We evaluated the financing transactions in accordance with ASC Topic 815, Derivatives and Hedging, and determined that the conversion feature of the convertible promissory note was not afforded the exemption for conventional convertible instruments due to its variable conversion rate. The note has no explicit limit on the number of shares issuable so they did not meet the conditions set forth in current accounting standards for equity classification. The Company elected to recognize the note under paragraph 815-15-25-4, whereby, there would be a separation into a host contract and derivative instrument. The Company elected to initially and subsequently measure the note in its entirety at fair value, with changes in fair value recognized in earnings. The Company recorded a derivative liability representing the imputed interest associated with the embedded derivative. The derivative liability is adjusted periodically per the stock price fluctuations. The convertible notes issued and described in Note 4 do not have fixed settlement provisions because their conversion prices are not fixed. The conversion feature has been characterized as derivative liabilities to be re-measured at the end of every reporting period with the change in value reported in the statement of operations. During the nine months ended September 30, 2019, the Company converted $460,135 in principal of convertible promissory notes, plus accrued interest of $100,557, and a default settlement loss in the amount of $77,924. As a result of the conversion of these notes and the change in fair value of the remaining notes, the Company recorded a loss on conversion of debt in the amount of $254,585 in the statement of operations for the nine months ended September 30, 2019. At September 30, 2019, the fair value of the derivative liability was $13,615,889. For purpose of determining the fair market value of the derivative liability for the embedded conversion, the Company used the Binomial lattice valuation model. The significant assumptions used in the Binomial lattice valuation model for the derivative are as follows: 9/30/19 Risk free interest rate 1.55% - 1.99 % Stock volatility factor 129.0% - 355.0 % Weighted average expected option life 1 months - 5 years Expected dividend yield None

Restricted Stock and Warrants

Restricted Stock and Warrants	9 Months Ended
	Sep. 30, 2019
Share-based Payment Arrangement [Abstract]
RESTRICTED STOCK AND WARRANTS	6. RESTRICTED STOCK AND WARRANTS Restricted Stock to CEO On May 12, 2016, the Company entered into a Restricted Stock Grant Agreement (the “RSGA”) with its Chief Executive Officer, Riggs Eckelberry, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the RSGA are performance based shares and none have yet vested nor have any been issued. The RSGA provides for the issuance of up to 857 shares of the Company’s common stock provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company’s quarterly or annual financial statements, the Company will issue up to 429 shares of its common stock; b) If the Company’s consolidated operating profit ( Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), On August 10, 2016, the Company entered into a Restricted Stock Grant Agreement (the “August RSGA”) with its Chief Executive Officer, Riggs Eckelberry, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the August RSGA are performance based shares and none have yet vested nor have any been issued. The August RSGA provides for the issuance of up to 857 shares of the Company’s common stock to the CEO provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue up to 429 shares of its common stock; b) If the Company’s consolidated operating profit ( Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), On May 16, 2018, the Company entered into a Restricted Stock Grant Agreement (the “May RSGA”) with its Chief Executive Officer, Riggs Eckelberry, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the May RSGA are performance based shares and none have yet vested nor have any been issued. The May RSGA provides for the issuance of up to 15,000 shares of the Company’s common stock to the CEO provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue up to 7,500 shares of its common stock; b) If the Company’s consolidated operating profit ( Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), On September 28, 2018, the Company entered into a Restricted Stock Grant Agreement (the “September RSGA”) with its Chief Executive Officer, Riggs Eckelberry, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the September RSGA are performance based shares and none have yet vested nor have any been issued. The September RSGA provides for the issuance of up to 15,000 shares of the Company’s common stock to the CEO provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue up to 7,500 shares of its common stock; b) If the Company’s consolidated operating profit ( Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), On April 19, 2019, the Company entered into Restricted Stock Grant Agreements (the “April RSGA”) with its Chief Executive Officer, Riggs Eckelberry to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the April RSGA are performance based shares and none have yet vested nor have any been issued. The April RSGA provide for the issuance of up to an aggregate of 15,000 shares of the Company’s common stock to the CEO provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue up to an aggregate of 7,500 shares of its common stock; b) If the Company’s consolidated operating profit ( Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), Restricted Stock to CEO On August 14, 2019, the Company entered into Restricted Stock Grant Agreements (the “Aug 2019 RSGA”) with its Chief Executive Officer, Riggs Eckelberry to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the Aug 2019 RSGA are performance based shares and none have yet vested nor have any been issued. The Aug 2019 RSGA provide for the issuance of up to an aggregate of 62,500 shares of the Company’s common stock to the CEO provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue up to an aggregate of 31,250 shares of its common stock; b) If the Company’s consolidated operating profit ( Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), Restricted Stock to Employees and Consultants On May 12, 2016, the Company entered into a Restricted Stock Grant Agreement (the “Employee RSGAs”) with two employees, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the Employee RSGAs are performance based shares and none have yet vested nor have any been issued. The Employee RSGAs provide to each of the employees the issuance of up to 429 shares of the Company’s common stock to the employee provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company’s quarterly or annual financial statements, the Company will issue to each of the employees up to 214 shares of its common stock; b) If the Company’s consolidated operating profit ( Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), On August 10, 2016, the Company entered into a Restricted Stock Grant Agreement (the “Consultants RSGA”) with two consultants, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the Consultants RSGA are performance based shares and none have yet vested nor have any been issued. The Consultants RSGA provides to each of the consultants the issuance of up to 143 shares of the Company’s common stock provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue to each of the consultants up to 71 shares of its common stock; b) If the Company’s consolidated operating profit ( Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), On November 10, 2017, the Company entered into a Restricted Stock Grant Agreement (the “Nov Employee RSGA”) with an employee, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the Nov Employee RSGA are performance based shares and none have yet vested nor have any been issued. The Nov Employee RSGA provides the issuance of up to 1,000 shares of the Company’s common stock provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue to the employee up to 500 shares of its common stock; b) If the Company’s consolidated operating profit ( Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), On May 16, 2018, the Company entered into a Restricted Stock Grant Agreement (the “Employee and Consultant RSGA”) with one employee and one consultant, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the Employee and Consultant RSGA are performance based shares and none have yet vested nor have any been issued. The Employee and Consultant RSGA provides to the employee and consultant the issuance of an aggregate of 2,000 shares of the Company’s common stock provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue to the employee and consultant an aggregate of 1,000 shares in common stock; b) If the Company’s consolidated operating profit ( Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), On August 9, 2018, the Company entered into a Restricted Stock Grant Agreement (the “Employee and Consultants RSGA”) with three consultants and one employee, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the Employee and Consultants RSGA are performance based shares and none have yet vested nor have any been issued. The Employee and Consultants RSGA provides to the employee and consultants the issuance of an aggregate of 4,250 shares of the Company’s common stock provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue to the employee and consultants in various amounts an aggregate of 2,125 shares in common stock; b) If the Company’s consolidated operating profit ( Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), On September 28, 2018, the Company entered into a Restricted Stock Grant Agreement (the “Sep 2018 Consultants RSGA”) with two consultants, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the Sep 2018 Consultants RSGA are performance based shares and none have yet vested nor have any been issued. The Sep 2018 Consultants RSGA provides to the consultants the issuance of an aggregate of 13,500 shares of the Company’s common stock provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue to the consultants in various amounts an aggregate of 6,750 shares in common stock; b) If the Company’s consolidated operating profit ( Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), On April 19, 2019, the Company entered into a Restricted Stock Grant Agreement (the “Apr 2019 RSGAs”) with three board members and five consultants, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the Apr 2019 RSGAs are performance based shares and none have yet vested nor have any been issued. The Apr 2019 RSGAs provide to the consultants and board members the issuance of an aggregate of 30,000 shares of the Company’s common stock provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue to the board members and consultants in various amounts an aggregate of 15,000 shares in common stock; b) If the Company’s consolidated operating profit ( Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), On August 14, 2019, the Company entered into a Restricted Stock Grant Agreement (the “Aug 2019 RSGAs”) with three board members, five consultants, and all full time employees to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the Aug 2019 RSGAs are performance based shares and none have yet vested nor have any been issued. The Aug 2019 RSGAs provide to the employees, consultants and board members the issuance of an aggregate of 327,000 shares of the Company’s common stock provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue to the holders in various amounts an aggregate of 163,500 shares in common stock; b) If the Company’s consolidated operating profit ( Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), On August 14, 2019, the Board of Directors approved an amendment to the Restricted Stock Grant Agreements (the “RSGAs”) to include an alternative vesting schedule for the Grantees. The Grantee can elect to participate in the alternate vesting schedule for grants received at least two years prior to the date requested. On the first day of each calendar month, an aggregate dollar amount of restricted stock equal to an aggregate of 5% of the total dollar amount of the Company’s common stock that traded during the prior calendar month, will vest, divided equally among all RSGAs that have duly elected to participate in the alternate vesting schedule, with value based on the fair market value under the respective RSGAs. Upon the occurrence of a Company performance goal, the right to participate in the alternate vesting schedule will terminate, and the vesting of the remaining unvested shares will be as set forth under the restricted stock award agreement. Warrants The Company issued no warrants during the nine months ended September 30, 2019. A summary of the Company’s warrant activity and related information follows for the nine months ended September 30, 2019: September 30, 2019 Weighted Number average of exercise Warrants price Outstanding -beginning of the period 125,456 $ 480.00 Granted - - Exercised - - Forfeited/Expired (3,412 ) $ 240.00 Outstanding - end of the period 122,044 $ 500.00 At September 30, 2019, the weighted average remaining contractual life of warrants outstanding: Weighted Average Remaining Exercisable Warrants Warrants Contractual Prices Outstanding Exercisable Life (years) $ 500.00 122,044 122,044 2.12 122,044 122,044 The warrants were adjusted for the reverse split at September 30, 2019, and the aggregate intrinsic value of the warrants outstanding was $0.

Revenue from Contracts with Cus

Revenue from Contracts with Customers	9 Months Ended
	Sep. 30, 2019
Revenue from Contracts with Customers [Abstract]
REVENUE FROM CONTRACTS WITH CUSTOMERS	7. REVENUE FROM CONTRACTS WITH CUSTOMERS Equipment Contracts Revenues and related costs on equipment contracts are recognized as the performance obligations for work are satisfied over time in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers. Under ASC 606, revenue and associated profit, will be recognized as the customer obtains control of the goods and services promised in the contract (i.e., performance obligations). All un-allocable indirect costs and corporate general and administrative costs are charged to the periods as incurred. However, in the event a loss on a contract is foreseen, the Company will recognize the loss as it is determined. The following table represents a disaggregation of revenue by type of good or service from contracts with customers for the nine months ended September 30, 2019 and 2018: Nine Months Ended September 30, 2019 2018 Equipment Contracts $ 1,830,217 $ 2,486,426 Component Sales 730,040 1,003,879 Services Sales 116,176 157,956 Licensing Fees 20,000 30,000 $ 2,696,433 $ 3,678,261 Revenue recognition for other sales arrangements, such as sales for components, service and licensing fees will remain materially consistent. Contract assets represents revenues recognized in excess of amounts billed on contracts in progress. Contract liabilities represents billings in excess of revenues recognized on contracts in progress. Assets and liabilities related to long-term contracts are included in current assets and current liabilities in the accompanying balance sheets, as they will be liquidated in the normal course of the contract completion. The contract asset for the nine months ending September 30, 2019 was $13,289 and for the year ending December 31, 2018 was $111,001. The contract liability for the nine months ending September 30, 2019 was $318,151 and for the year ending December 31, 2018 was $112,894.

Financial Assets

Financial Assets	9 Months Ended
	Sep. 30, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
FINANCIAL ASSETS	8. FINANCIAL ASSETS Convertible Note Receivable The Company purchased a 10% convertible note in the amount of $80,000, through a private placement with Water Technologies International, Inc (“WTII”). The Note is convertible into common stock of WTII at a price of 65% of the lowest trading price for the ten (10) trading days immediately prior to the conversion date. The conversion price shall not be lower than a price of $0.0001 per share. The Note bears a default clause, which increases the rate of interest to 20% automatic late fee on the unpaid balance, plus the monthly interest increases to 20%, if the accrued interest is not paid per the agreement every six months. As of September 30, 2019, the issuer defaulted on the convertible note, and was charged $20,980 in interest for the period. As of September 30, 2019, the note included principal of $80,000 plus accrued interest of $33,879. Fair value investment in Securities On May 15, 2018, the Company received 4,000 shares of WTII preferred stock for the use of OriginClear, Inc. technology associated with their proprietary electro water separation system. The stock was valued at fair market value of $0.0075 for a price of $30,000 on the date of issuance. The preferred shares are convertible into 4,000,000 shares of common stock. The Company analyzed the licensing agreement using ASU 606 to determine the timing of revenue recognition. The licensing of the intellectual property (IP) is distinct from the non-license goods or services and has significant standalone functionality that provides a benefit or value. The functionality will not change during the license period due to the licensor’s activities. Because the significant standalone functionality was delivered immediately, the revenue was recognized in the financial statements as of June 30, 2018. As of September 30, 2019, the fair value of the preferred shares was $14,000.

Loans Payable

Loans Payable	9 Months Ended
	Sep. 30, 2019
Loans Payable [Abstract]
LOANS PAYABLE	9. LOANS PAYABLE Secured Loans Payable The Company entered into short term loans with various lenders for capital expansion secured by the Company's assets in the amount of $1,749,970, which included finance cost of $624,810. The finance cost was amortized over the terms of the loans, which have various maturity dates ranging from October 2018 through February 2019. The term of the loans ranged from two months to six months. The net balance as of September 30, 2019 was $514,181, less finance cost of $12,566 for a net balance of $501,615. Promissory Note Payable The Company issued a promissory note on July 18, 2018 for the sum of $75,000. The principal consisted of $67,500 plus a $7,500 origination fee. The interest rate was sixty-nine percent per annum. The monthly payments were $4,318, and the maturity date of the Note was August 1, 2028. The note was personally guaranteed by the Company's CEO. As of September 30, 2019, the note was paid in full. Loan Payable – Related Party The Company's CEO loaned the Company $248,870 during the year ended December 31, 2018. The loans bear interest at various rates and have various maturity dates. The funds were used for operating expenses. The principal balance as December 31, 2018 was $219,841. During the nine months ended September 30, 2019, additional funds were received in the amount of $35,000. The Company made principal payments in the amount of $48,264, leaving a balance of $206,577 as of September 30, 2019.

Capital Leases

Capital Leases	9 Months Ended
	Sep. 30, 2019
Leases [Abstract]
CAPITAL LEASES	10. CAPITAL LEASES The Company entered into a capital lease for the purchase of equipment during the year ended December 31, 2018 with a purchase option at the end of the lease for $1.00. Capital Lease – Equipment The Company entered into a five (5) year equipment lease in the amount of $45,440, which was recorded as a capital lease. The lease is for a sixty (60) month term, and there are no escalation or renewal options associated with this lease. The lease has a purchase option to buy the equipment at the end of the lease for one dollar ($1). The monthly lease payments are $757 per month. The future minimum lease payments due as of September 30, 2019 total $28,433. As of September 30, 2019, the maturities are summarized as follows: Capital lease $ 28,433 Less current portion 9,088 Total long-term liabilities $ 19,345 Long term maturities for the next three years are as follows: Period Ending September 30, 2019 $ 9,088 2020 9,088 2021 1,169 $ 19,345

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2019
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	11. COMMITMENTS AND CONTINGENCIES Office Space Rental The Company entered into a month-to-month rental agreement with a shareholder of the Company for office space in McKinney, Texas at a base rent of $4,850 per month. Warranty Reserve Generally, a PWT project is guaranteed against defects in material and workmanship for one year from the date of completion, while certain areas of construction and materials may have guarantees extending beyond one year. The Company has various insurance policies relating to the guarantee of completed work, which in the opinion of management will adequately cover any potential claims. A warranty reserve has been provided under PWT based on the opinion of management and based on Company history in the amount of $20,000. The Company accrues for loss contingencies arising from claims, litigation and other sources when it is probable that a liability has been incurred and the amount can be reasonably estimated. These accruals are adjusted periodically as assessments change or additional information becomes available. Legal costs incurred in connection with loss contingencies are expensed as incurred. The Company has no current legal proceeding and did not accrue any loss for contingencies as of September 30, 2019 and December 31, 2018.

Deferred Revenue

Deferred Revenue	9 Months Ended
	Sep. 30, 2019
Revenue Recognition and Deferred Revenue [Abstract]
DEFERRED REVENUE	12. DEFERRED REVENUE The Company recognizes revenue when services are performed, and at the time of shipment of products, provided that evidence of an arrangement exists, title and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured. The Company received a deposit from a customer in the amount of $71,917 to perform a service, which has not been provided as of September 30, 2019.

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2019
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	13. SUBSEQUENT EVENTS Management has evaluated subsequent events according to the requirements of ASC TOPIC 855 and has determined that there are the following subsequent events: Between October 4, 2019 and November 14, 2019, the Company entered into subscription agreements with certain accredited investors pursuant to which the Company sold an aggregate of 409.5 shares of the Company’s Series K preferred stock for an aggregate purchase price of $409,500. The Company also issued an aggregate of 204.75 shares of its Series L preferred stock to the investors. Between October 17, 2019 and November 13, 2019, holders of convertible notes, converted an aggregate outstanding principal and interest amount of $40,429 into an aggregate of 703,618 shares of the Company’s common stock. In connection with certain one-time make good agreements, on October 31, 2019, the Company issued an aggregate of 19,341 shares of its common stock to certain holders of its common stock. Between November 8, 2019 and November 11, 2019 the Company issued to consultants an aggregate of 93,334 shares of the Company’s common stock for services. On November 19, 2019, the Company filed a Certificate of Withdrawal of Certificate of Designation, with the Secretary of State of Nevada, to withdraw the Company’s Certificate of Designation of Series D Preferred Stock.

Summary of Significant Accoun_2

Summary of Significant Accounting Polices (Policies)	9 Months Ended
	Sep. 30, 2019
Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation The accompanying unaudited condensed consolidated financial statements include the accounts of OriginClear, Inc. and its wholly owned operating subsidiaries, Progressive Water Treatment, Inc., and OriginClear Technology Limited. All material intercompany transactions have been eliminated upon consolidation of these entities.
Loss per Share Calculations	Loss per Share Calculations Basic loss per share calculations are computed by dividing income (loss) available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed similar to basic earnings per share except that the denominator is increased to include securities or other contracts to issue common stock that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. Nine months ended September 30, 2019 The Company has excluded 122,044 shares of common stock issuable pursuant to outstanding warrants, shares of common stock issuable pursuant to outstanding convertible debt of $3,638,893, and shares issuable upon conversion of convertible preferred stock for the three and nine months ended September 30, 2019, because their impact on the loss per share is anti-dilutive. Nine Months Ended September 30, 2018 The Company has excluded 1,80582, stock options, 130,575 warrants, convertible debt of $3,494,546 and shares issuable upon conversion of convertible preferred stock for the nine months ended September 30, 2018, because their impact on the loss per share is anti-dilutive. The Company did include convertible debt of $549,308 in its diluted earnings per share, because their impact on the earnings per share is dilutive.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include estimates used to review the Company's impairments and estimations of long-lived assets, revenue recognition on percentage of completion type contracts, allowances for uncollectible accounts, warranty reserves, inventory valuation, debt beneficial conversion features, fair value investments, valuations of non-cash capital stock issuances and the valuation allowance on deferred tax assets. The Company bases its estimates on historical experience and on various other assumptions the Company believes to be reasonable in the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.
Stock-Based Compensation	Stock-Based Compensation The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by the Financial Accounting Standards Board whereas the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option and warrant grants issued and vesting to non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option grants are immediately vested and the total stock-based compensation charge is recorded in the period of the measurement date.
Revenue Recognition	Revenue Recognition We recognize revenue when services are performed, and at the time of shipment of products, provided that evidence of an arrangement exists, title and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured. Revenues and related costs on construction contracts are recognized as the performance obligations for work are satisfied over time in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers. Under ASC 606, revenue and associated profit, will be recognized as the customer obtains control of the goods and services promised in the contract (i.e., performance obligations). All un-allocable indirect costs and corporate general and administrative costs are charged to the periods as incurred. However, in the event a loss on a contract is foreseen, the Company will recognize the loss as it is determined. Revisions in cost and profit estimates during the course of the contract are reflected in the accounting period in which the facts for the revisions become known. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions, and estimated profitability, including those arising from contract penalty provisions, and final contract settlements, may result in revisions to costs and income, which are recognized in the period the revisions are determined. Contract receivables are recorded on contracts for amounts currently due based upon progress billings, as well as retention, which are collectible upon completion of the contracts. Accounts payable to material suppliers and subcontractors are recorded for amounts currently due based upon work completed or materials received, as are retention due subcontractors, which are payable upon completion of the contract. General and administrative expenses are charged to operations as incurred and are not allocated to contract costs.
Contract Receivable	Contract Receivable The Company bills its customers in accordance with contractual agreements. The agreements generally require billing to be on a progressive basis as work is completed. Credit is extended based on evaluation of clients' financial condition and collateral is not required. The Company maintains an allowance for doubtful accounts for estimated losses that may arise if any customer is unable to make required payments. Management performs a quantitative and qualitative review of the receivables past due from customers on a monthly basis. The Company records an allowance against uncollectible items for each customer after all reasonable means of collection have been exhausted, and the potential for recovery is considered remote. The allowance for doubtful accounts were $0 as of September 30, 2019 and $6,996 as of December 31, 2018. The net contract receivable balance was $454,521 and $309,223 at September 30, 2019 and December 31, 2018, respectively.
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair Value of Financial Instruments, requires disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of September 30, 2019, the balances reported for cash, contract receivables, contract assets, prepaid expenses, accounts payable, contract liabilities, and accrued expenses, and derivative instruments approximate the fair value because of their short maturities. We adopted ASC Topic 820 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The following table presents certain investments and liabilities of the Company’s financial assets and liabilities measured and recorded at fair value on the Company’s balance sheets on a recurring basis and their level within the fair value hierarchy as of September 30, 2019. Total (Level 1) (Level 2) (Level 3) Investment at fair value-securities $ 14,000 $ 14,000 $ - $ - Total Assets measured at fair value $ 14,000 $ 14,000 $ - $ - Total (Level 1) (Level 2) (Level 3) Derivative Liability $ 13,615,889 $ - $ - $ 13,615,889 Total liabilities measured at fair value $ 13,615,889 $ - $ - $ 13,615,889 The following is a reconciliation of the derivative liability for which level 3 inputs were used in determining the approximate fair value: Balance as of January 1, 2019 $ 9,360,204 Fair Value of derivative liabilities issued - Loss on net change in derivative liability 4,255,685 Balance as of September 30, 2019 $ 13,615,889
Segment Reporting	Segment Reporting The Company’s business currently operates in one segment based upon the Company’s organizational structure and the way in which the operations are managed and evaluated.
Marketable Securities	Marketable Securities The Company adopted ASU 2016-01, “Financial Instruments – Recognition and Measurement of Financial Assets and Financial Liabilities.” ASU 2016-01 requires investments (except those accounted for under the equity method of accounting, or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income. It requires public business entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purpose, and separate presentation of financial assets and financial liabilities by measurement category and form of financial asset. It eliminates the requirement for public business entities to disclose the method(s) and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost. The Company has evaluated the potential impact this standard may have on the condensed consolidated financial statements and determined that it had a significant impact on the condensed consolidated financial statements. The Company accounts for its investment in Water Technologies International, Inc. as available-for-sale securities, and the unrealized gain on the available-for-sale securities is recognized in net income.
Licensing agreement	Licensing agreement The Company analyzed the licensing agreement using ASU 606 to determine the timing of revenue recognition. The licensing of the intellectual property (IP) is distinct from the non-license goods or services and has significant standalone functionality that provides a benefit or value. The functionality will not change during the license period due to the licensor’s activities. Because the significant standalone functionality is delivered immediately, the revenue is generally recognized when the license is delivered.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements In February 2016, the FASB established ASC Topic 842, Leases (Topic 842), by issuing ASU No. 2016-02, which requires lessees to recognize leases on-balance sheet and disclose key information about leasing arrangements. Topic 842 was subsequently amended by ASU No. 2018-01, Land Easement Practical Expedient for Transition to Topic 842; ASU No. 2018-10, Codification Improvements to Topic 842, Leases; and ASU No. 2018-11, Targeted Improvements. The new standard establishes a right-of-use (ROU) model that requires a lessee to recognize a ROU asset and lease liability on the balance sheet. Leases will be classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the statement of operations. The Company adopted the new standard on January 1, 2019. The new standard provides a number of optional practical expedients in transition. The Company has elected the 'package of practical expedients', which permit it not to reassess under the new standard its prior conclusions about lease identification, lease classification and initial direct costs. The Company did not elect the use-of-hindsight or the practical expedient pertaining to land easements; the latter is not applicable to the Company. The new standard did not have a material impact on the Company's unaudited condensed consolidated financial statements. In August 2017, FASB issued accounting standards update ASU-2017-12, "D" (Topic 815) – "Targeted Improvements to Accounting for Hedging Activities", to require an entity to present the earnings effect of the hedging instrument in the same statement line item in which the earnings effect of the hedged item is reported. The amendments in this update are effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods with the fiscal years beginning after December 15, 2020. Early adoption is permitted in any interim period after issuance of the update. The Company has evaluated the impact of the adoption of ASU 2017-12 on the Company's unaudited condensed consolidated financial statements, which had no material impact. In June 2018, FASB issued accounting standards update ASU 2018-07, (Topic 505) – "Shared-Based Payment Arrangements with Nonemployees", which simplifies the accounting for share-based payments granted to nonemployees for goods and services. Under the ASU, most of the guidance on such payments to nonemployees will be aligned with the requirements for share-based payments granted to employees. Under the ASU 2018-07, the measurement of equity-classified nonemployee share-based payments will be fixed on the grant date, as defined in ASC 718, and will use the term nonemployee vesting period, rather than requisite service period. The amendments in this update are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early adoption is permitted if financial statements have not yet been issued. The Company adopted ASU 2018-07 on the January 1, 2019. The adoption of the new standard did not have a material impact on the Company's unaudited condensed consolidated financial statements. Management reviewed currently issued pronouncements and does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying unaudited condensed consolidated financial statements.
Reclassification of Expenses	Reclassification of Expenses During the nine months ended September 30, 2019, certain expenses were reclassified in the financial statements, which had no material effect.

Summary of Significant Accoun_3

Summary of Significant Accounting Polices (Tables)	9 Months Ended
	Sep. 30, 2019
Accounting Policies [Abstract]
Schedule of fair value of financial instruments	Total (Level 1) (Level 2) (Level 3) Investment at fair value-securities $ 14,000 $ 14,000 $ - $ - Total Assets measured at fair value $ 14,000 $ 14,000 $ - $ -
Schedule of fair value of (liability) financial instruments	Total (Level 1) (Level 2) (Level 3) Derivative Liability $ 13,615,889 $ - $ - $ 13,615,889 Total liabilities measured at fair value $ 13,615,889 $ - $ - $ 13,615,889
Schedule of reconciliation of the derivative liability for which level 3 inputs	Balance as of January 1, 2019 $ 9,360,204 Fair Value of derivative liabilities issued - Loss on net change in derivative liability 4,255,685 Balance as of September 30, 2019 $ 13,615,889

Convertible Promissory Notes (T

Convertible Promissory Notes (Tables)	9 Months Ended
	Sep. 30, 2019
Debt Disclosure [Abstract]
Schedule of outstanding convertible promissory notes	Convertible Promissory Notes $ 3,638,893 Less current portion 2,911,944 Total long-term liabilities $ 726,949
Schedule of maturities of long-term debt	Period Ending September 30, 2019 Amount 2020 2,911,944 2021 125,000 2022 - 2023 73,128 2024 528,821 $ 3,638,893

Derivative Liabilities (Tables)

Derivative Liabilities (Tables)	9 Months Ended
	Sep. 30, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of fair market value of the derivative liability	9/30/19 Risk free interest rate 1.55% - 1.99 % Stock volatility factor 129.0% - 355.0 % Weighted average expected option life 1 months - 5 years Expected dividend yield None

Restricted Stock and Warrants (

Restricted Stock and Warrants (Tables)	9 Months Ended
	Sep. 30, 2019
Share-based Payment Arrangement [Abstract]
Schedule of warrant activity	September 30, 2019 Weighted Number average of exercise Warrants price Outstanding -beginning of the period 125,456 $ 480.00 Granted - - Exercised - - Forfeited/Expired (3,412 ) $ 240.00 Outstanding - end of the period 122,044 $ 500.00
Schedule of weighted average remaining contractual life of warrants outstanding	Weighted Average Remaining Exercisable Warrants Warrants Contractual Prices Outstanding Exercisable Life (years) $ 500.00 122,044 122,044 2.12 122,044 122,044

Revenue from Contracts with C_2

Revenue from Contracts with Customers (Tables)	9 Months Ended
	Sep. 30, 2019
Revenue from Contracts with Customers [Abstract]
Schedule of disaggregation of revenue by type of good or service from contracts with customers	Nine Months Ended September 30, 2019 2018 Equipment Contracts $ 1,830,217 $ 2,486,426 Component Sales 730,040 1,003,879 Services Sales 116,176 157,956 Licensing Fees 20,000 30,000 $ 2,696,433 $ 3,678,261

Capital Leases (Tables)

Capital Leases (Tables)	9 Months Ended
	Sep. 30, 2019
Leases [Abstract]
Schedule of maturities	Capital lease $ 28,433 Less current portion 9,088 Total long-term liabilities $ 19,345
Schedule of long term maturities	Period Ending September 30, 2019 $ 9,088 2020 9,088 2021 1,169 $ 19,345

Summary of Significant Accoun_4

Summary of Significant Accounting Polices (Details)	Sep. 30, 2019USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment at fair value-securities	$ 14,000
Total Assets measured at fair value	14,000
Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment at fair value-securities	14,000
Total Assets measured at fair value	14,000
Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment at fair value-securities
Total Assets measured at fair value
Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment at fair value-securities
Total Assets measured at fair value

Summary of Significant Accoun_5

Summary of Significant Accounting Polices (Details 1) - USD ($)	Sep. 30, 2019	Dec. 31, 2018
Schedule of fair value of financial instruments
Derivative Liability	$ 13,615,889	$ 9,360,204
Total liabilities measured at fair value	13,615,889
Level 1 [Member]
Schedule of fair value of financial instruments
Derivative Liability
Total liabilities measured at fair value
Level 2 [Member]
Schedule of fair value of financial instruments
Derivative Liability
Total liabilities measured at fair value
Level 3 [Member]
Schedule of fair value of financial instruments
Derivative Liability	13,615,889
Total liabilities measured at fair value	$ 13,615,889

Summary of Significant Accoun_6

Summary of Significant Accounting Polices (Details 2) - Fair Value, Inputs, Level 3 [Member]	9 Months Ended
	Sep. 30, 2019USD ($)
Schedule of reconciliation of the derivative liability for which Level 3 inputs
Beginning balance	$ 9,360,204
Fair Value of derivative liabilities issued
Loss on net change in derivative liability	4,255,685
Ending balance	$ 13,615,889

Summary of Significant Accoun_7

Summary of Significant Accounting Polices (Details Textual)	3 Months Ended	9 Months Ended
	Sep. 30, 2019USD ($)	Sep. 30, 2019USD ($)Segmentsshares	Sep. 30, 2018USD ($)shares	Dec. 31, 2018USD ($)
Summary of Significant Accounting Polices (Textual)
Allowance for doubtful accounts	$ 0	$ 0		$ 6,996
Contract receivable	454,521	$ 454,521		$ 309,223
Number of segment reporting | Segments		1
Outstanding convertible debt			$ 750,500
Convertible Debt [Member]
Summary of Significant Accounting Polices (Textual)
Outstanding convertible debt			$ 549,308
Warrant [Member]
Summary of Significant Accounting Polices (Textual)
Antidilutive securities excluded from computation of earnings per share | shares		122,044	130,575
Employee Stock Option [Member]
Summary of Significant Accounting Polices (Textual)
Antidilutive securities excluded from computation of earnings per share | shares			180,582
Common Stock [Member]
Summary of Significant Accounting Polices (Textual)
Outstanding convertible debt	$ 3,638,893	$ 3,638,893	$ 3,494,546

Capital Stock (Details)

Capital Stock (Details) - USD ($)	Apr. 03, 2019	Aug. 14, 2018	Apr. 13, 2018	Mar. 14, 2017	Jun. 03, 2019	Apr. 23, 2019	Jan. 16, 2019	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018
Capital Stock (Textual)
Preferred stock, shares authorized								550,000,000		550,000,000
Fair value loss on settlement								$ 77,924
Common stock, shares authorized								16,000,000,000		16,000,000,000
Common Stock [Member]
Capital Stock (Textual)
Common stock for settlement of convertible promissory notes								1,396,552	6,597
Aggregate principal amount								$ 460,135	$ 88,000
Interest amount								$ 100,557	$ 30,743
Common stock issued for services, shares								744,333	13,226
Common stock issued for services								$ 623,141	$ 752,914
Debt conversion amount								254,585	$ 263,790
Fair value loss on settlement								$ 77,924
Description of reverse split								The Company filed a certificate of amendment to its articles of incorporation, with the State of Nevada effectuating a reverse split of the Company’s common stock at a ratio of 1 for 2,000.
Common Stock [Member] | Minimum [Member]
Capital Stock (Textual)
Conversion price								$ 0.40	$ 38
Common Stock [Member] | Maximum [Member]
Capital Stock (Textual)
Conversion price								$ 3.60	$ 65.80
Preferred Stock [Member]
Capital Stock (Textual)
Description of convertible preferred stock terms			The Board of Directors authorized an increase in shares of preferred stock, par value $0.0001 per share to 550,000,000 shares from 750,000 shares.
Series C Preferred Stock [Member]
Capital Stock (Textual)
Preferred stock, par value				$ 0.0001
Preferred stock, shares outstanding								1,000		1,000
Purchase price of the Series C preferred stock				$ 0.10
Total purchase price Series C preferred stock, shares				1,000
Series C Preferred Stock [Member] | President [Member]
Capital Stock (Textual)
Preferred stock, shares issued				1,000
Series D Preferred Stock [Member]
Capital Stock (Textual)
Description of convertible preferred stock terms			The Company filed a Certificate of Designation of Series D preferred stock (the “Series D preferred stock”) with the Secretary of State of Nevada, designating 400,000,000 shares of its authorized preferred stock as 0% Series D preferred stock, with a par value of $0.0001 per share. The shares of Series D preferred stock did not have a dividend rate or liquidation preference and did not carry any voting rights. As of August 14, 2018, the Series D preferred stock were cancelled, and exchanged for Series E preferred shares.
Series D Preferred Stock One [Member]
Capital Stock (Textual)
Preferred stock, shares issued								38,500,000
Preferred stock, shares outstanding								38,500,000		38,500,000
Description of convertible preferred stock terms			The Company filed a Certificate of Designation for its Series D-1 Convertible preferred stock (the “Series D-1 preferred stock”) with the Secretary of State of Nevada designating 50,000,000 shares of its authorized preferred stock as Series D-1 preferred stock, with a par value of $0.0001 per share. The shares of Series D-1 preferred stock do not have a dividend rate or liquidation preference. Each share of Series D-1 preferred stock is convertible into one share of common stock, adjusted for any stock splits with respect to the shares. The shares of Series D-1 preferred stock do not carry any voting rights. At no time may all or a portion of the Series D-1 preferred stock be converted if the number of shares of common stock to be issued pursuant to such conversion would exceed, when aggregated with all other shares of common stock owned by the holder at such time, the number of shares of common stock that would result in the holder beneficially owning more than 4.99% of all of the common stock outstanding at such time, which amount may be increased to 9.99% at the holder’s discretion upon 61 days written notice. The Company issued an aggregate of 38,500,000 Series D-1 preferred shares for services. As of September 30, 2019, there were 38,500,000 Series D-1 preferred shares issued and outstanding.
Series E Preferred Stock [Member]
Capital Stock (Textual)
Preferred stock, shares outstanding								2,139,649		2,139,649
Description of convertible preferred stock terms		The Company filed a Certificate of Designation for its 0% Series E Convertible preferred stock (the “Series E preferred stock”) with the Secretary of State of Nevada designating 4,000,000 shares of its authorized preferred stock as Series E preferred stock. The shares of Series E preferred stock have a par value of $0.0001 per share. The shares of Series E preferred stock do not have a dividend rate or liquidation preference. Each share of Series E preferred stock is convertible into a number of shares of common stock equal to the greater of (A) 100 shares of common stock and (B) the number of shares of common stock the holder would have received pursuant to such holder’s respective subscription agreement if the preferred shares were priced based on the average closing sale price of the common stock during the three trading days prior to the date the holder requests a conversion, provided the lowest price for which an adjustment will be made is 50% of the purchase price paid by any purchase of the Series E preferred stock, adjusted for any stock splits with respect to the shares. The shares of Series E preferred stock do not carry any voting rights. At no time may all or a portion of the Series E preferred stock be converted if the number of shares of common stock to be issued pursuant to such conversion would exceed, when aggregated with all other shares of common stock owned by the holder at such time, the number of shares of common stock that would result in the holder beneficially owning more than 4.99% of all of the common stock outstanding at such time, which amount may be increased to 9.99% at the holders discretion upon 61 days written notice. As of September 30, 2019, there were 2,139,649 shares of Series E preferred stock issued and outstanding. In connection with the issuance of the Series E preferred stock, the Company also issued one hundred warrants to purchase shares of common stock for each share of Series E preferred stock.
Series F Preferred Stock [Member]
Capital Stock (Textual)
Preferred stock, shares issued								1,678
Preferred stock, shares outstanding								1,678
Description of convertible preferred stock terms		The Company filed a Certificate of Designation for its Series F Convertible preferred stock (the “Series F preferred stock”) with the Secretary of State of Nevada designating 6,000 shares of Series F Preferred Stock. The shares of Series F preferred stock have a par value of $0.0001 per share. The shares of Series F preferred stock have a liquidation preference of stated value per share of $1,000 per share plus any accrued but unpaid dividends thereon before any distribution or payment may be made to the holders of any common stock or any other series of capital stock then-existing or thereinafter created. The stated value of Series F preferred stock is $1,000 per share and holders of Series F preferred stock are entitled to cumulative dividends at the annual rate of 8% of the stated value, payable quarterly. The shares of Series F preferred stock do not carry any voting rights. The Company may, in its sole discretion, at any time while the Series F preferred stock is outstanding, redeem all or any portion of the outstanding Series preferred stock at a price equal to the stated value, plus any accrued but unpaid dividends. The Company may exercise such redemption right by providing a minimum of 5 days written notice of such redemption to the Holders. In the event the Company exercises such redemption right for less than all of the then-outstanding shares of Series F preferred stock, the Company shall redeem the outstanding shares of the Holders of a pro-rata basis. The Series F is mandatorily redeemable on September 1, 2020. The Series F Preferred Stock is not convertible into common stock. As of September 30, 2019, the Company accrued dividends in the amount of $33,560. As of September 30, 2019, there were 1,678 shares of Series F preferred stock issued and outstanding.
Series G Preferred Stock [Member]
Capital Stock (Textual)
Issuance of common stock, shares								82,799
Description of convertible preferred stock terms							The Company filed a Series G Certificate of Designation with the Nevada Secretary of State (the “Series G Designation”). Pursuant to the Series G Certificate of Designation, the Company may issue up to 6,000 shares of Series G preferred stock, each share having a stated value of $1,000 per share and holders of Series G preferred stock are entitled to cumulative dividends at the annual rate of 8% of the stated value, payable quarterly. Pursuant to certain subscription agreements entered into with purchasers of the Series G preferred stock, each purchaser shall receive shares of the Company’s common stock equal to an amount of, for each share of Series G preferred stock purchased, five hundred dollars ($500) divided by the closing price on the date the Company receives the executed subscription documents and purchase price from such investor. Between January 16, 2019 and March 20, 2019, the Company entered into subscription agreements with certain accredited investors pursuant to which the Company sold an aggregate of 530 shares of the Company’s Series G preferred stock for an aggregate purchase price of $530,000. As of September 30, 2019, the Company issued an aggregate of 82,799 shares of its common stock to certain holders of its Series G preferred stock.
Accrued dividends								$ 10,600
Series I / J Preferred Stock [Member]
Capital Stock (Textual)
Description of convertible preferred stock terms	The Company filed a Series I Certificate of Designation (the “Series I COD”) for its Series I Preferred Stock (the “Series I”) and a Series J Certificate of designation (the “Series J COD”) for its Series J Preferred Stock (the “Series J”) with the Nevada Secretary of State. Pursuant to the Series I COD, the Company designated 4,000 shares of preferred stock as Series I. The Series I has a stated value of $1,000 per share. Series I holders are entitled to cumulative dividends at the annual rate of 8% of the stated value, payable quarterly within 60 days from the end of each fiscal quarter. The Series I will not be entitled to any voting rights except as may be required by applicable law, and will not be convertible into common stock. The Company will have the right to redeem the Series I at any time while the Series I are outstanding at a price equal to the stated value plus any accrued but unpaid dividends. The Company will be required to redeem the Series I two years following the date that is the later of the (i) final closing of the tranche (as designated in the applicable subscription agreement) or (ii) the expiration date of the tranche that such shares to be redeemed were a part of. Pursuant to the Series J COD, the Company designated 100,000 shares of preferred stock as Series J. The Series J has a stated value of $1,000 per share and holders will be entitled to receive dividends on an as-converted basis with the Company’s common stock. The Series J preferred stock is convertible into shares of the Company’s common stock, on the terms and conditions set forth in the Series J COD, which includes certain Make-Good Shares for certain holders of the Company’s previously disclosed Series F preferred stock and Series G preferred stock. As of September 30, 2019, the Company issued an aggregate of 797.4 shares of its Series I preferred stock and 398.7 shares of its Series J preferred stock.
Accrued dividends								15,948
Series K / L Preferred Stock [Member]
Capital Stock (Textual)
Description of convertible preferred stock terms					The Company executed a Series K Certificate of Designation (the “Series K COD”) for its Series K Preferred Stock (the “Series K”) and a Series L Certificate of designation (the “Series L COD”) for its Series L Preferred Stock (the “Series L”). Pursuant to the Series K COD, the Company designated 4,000 shares of preferred stock as Series K. The Series K has a stated value of $1,000 per share. Series K holders are entitled to cumulative dividends at the annual rate of 8% of the stated value, payable quarterly within 60 days from the end of each fiscal quarter. The Series K will not be entitled to any voting rights except as may be required by applicable law, and will not be convertible into common stock. The Company will have the right to redeem the Series K at any time while the Series K are outstanding at a price equal to the stated value plus any accrued but unpaid dividends. The Company will be required to redeem the Series K two years following the date that is the later of the (i) final closing of the tranche (as designated in the applicable subscription agreement) or (ii) the expiration date of the tranche that such shares to be redeemed were a part of. Pursuant to the Series L COD, the Company designated 100,000 shares of preferred stock as Series L. The Series L has a stated value of $1,000 per share and holders will be entitled to receive dividends on an as-converted basis with the Company’s common stock. The Series L preferred stock is convertible into validly-issued, fully paid and non-assessable shares of the Company’s common stock, on the terms and conditions set forth in the Series L COD, which includes certain Make-Good Shares for certain holders of the Company’s previously disclosed investment rounds. As of September 30, 2019, the Company issued an aggregate of 1,265.15 shares of its Series K preferred stock and 632.58 shares of its Series L preferred stock.
Accrued dividends								$ 14,519
Common Stock [Member]
Capital Stock (Textual)
Description of convertible preferred stock terms						The Company filed a Certificate of Amendment to its Articles of Incorporation, with the Secretary of State of the State of Nevada to effectuate an increase to the number of authorized shares of common stock of the Company from 8,000,000,000 to 16,000,000,000.

Convertible Promissory Notes (D

Convertible Promissory Notes (Details) - USD ($)	Sep. 30, 2019	Dec. 31, 2018
Debt Disclosure [Abstract]
Convertible Promissory Notes	$ 3,638,893
Less current portion	2,911,944	$ 1,580,955
Total long-term liabilities	$ 726,949

Convertible Promissory Notes _2

Convertible Promissory Notes (Details 1) - Convertible Promissory Notes [Member]	Sep. 30, 2019USD ($)
Maturities of long-term debt
2020	$ 2,911,944
2021	125,000
2022
2023	73,128
2024	528,821
Total	$ 3,638,893

Convertible Promissory Notes _3

Convertible Promissory Notes (Details Textual) - USD ($)	Mar. 13, 2019	Nov. 30, 2018	Feb. 23, 2018	Aug. 28, 2018	Sep. 30, 2019	Dec. 31, 2018
Convertible Promissory Notes (Textual)
Convertible promissory notes					$ 726,949	$ 2,076,472
Debt instrument, maturity date		Nov. 30, 2019
Derivative liability					13,615,889	9,360,204
Aggregate remaining amount					206,577
Fair value loss on settlement					77,924
Loss on conversion of debt					254,585
Issued an unsecured convertible promissory notes		$ 75,000
Convertible Promissory Notes [Member]
Convertible Promissory Notes (Textual)
Convertible promissory notes					3,638,893
Converted an aggregate principal amount					$ 165,300
Number of shares converted into common stock					584,184
Derivative liability					$ 430,896
Aggregate remaining amount					1,114,000
Accrued interest					$ 74,284
Conversion price per share of debt, description					50% of the lowest trade price on any trade day following issuance of the 2015-2016 Notes.
Fair value loss on settlement					$ 407,649
Convertible Debt One [Member]
Convertible Promissory Notes (Textual)
Recognized interest expense					$ 430,896
Description of debt instrument					Note has zero stated interest rate, and the conversion price shall be equal to 75% of the average three lowest last sale prices traded during the 25 trading days immediately prior to conversion.
Conversion of accounts payable into a convertible note					$ 430,896
Original Issue Discount Notes [Member]
Convertible Promissory Notes (Textual)
Remaining debt discount					$ 73,128
Debt instrument, maturity date					Jun. 30, 2018
Accrued interest						$ 143,228
Conversion price of debt					$ 15.31
Conversion price per share of debt, description					The OID Notes included an original issue discount and one time interest, which has been fully amortized. The OID Notes matured on June 30, 2018, and were extended through June 30, 2023. The OID Notes were convertible into shares of the Company’s common stock at a conversion price initially of $30,620. After the amendment, the conversion price changed to the lesser of $5,600 per share, or b) fifty percent (50%) of the lowest trade price of common stock recorded since the original effective date of this note, or c) the lowest effective price per share granted to any person or entity after the effective date.
2015-2016 Notes [Member]
Convertible Promissory Notes (Textual)
Description of debt instrument					On various dates ending on May 19, 2016. The 2015-2016 Notes matured and were extended from the date of each tranche through maturity dates ending on May 19, 2020. The 2015-2016 Notes bear interest at 10% per annum. The 2015-2016 Notes may be converted into shares of the Company’s common stock at conversion prices ranging from the lesser of $1,400.00 to $5,600 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the 2015-2016 Notes. The conversion feature of the 2015-2016 Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the 2015-2016 Notes. The remaining balance of the 2015-2016 Notes as of September 30, 2019, was $1,325,000.
Sep 2016 Note [Member]
Convertible Promissory Notes (Textual)
Description of debt instrument					In exchange for an accounts payable in the amount of $430,896, which could be converted into shares of the Company’s common stock after September 15, 2016. The Sep 2016 Note was accounted for under ASC 470, whereby, a beneficial conversion feature was recorded at time of issuance. On September 15, 2016, the Sep 2016 Note met the criteria of a derivative and was accounted for under ASC 815. The Sep 2016 Note has zero stated interest rate, and the conversion price shall be equal to 75% of the average three lowest last sale prices traded during the 25 trading days immediately prior to conversion. The Sep 2016 Note did not meet the criteria of a derivative at the time it was entered into, and was accounted for as a beneficial conversion feature, which was amortized over the life of the Sep 2016 Note and recognized as interest expense in the financial statements. The conversion feature of the Sep 2016 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion feature of the Sep 2016 Note. As of September 30, 2019, the remaining balance on the Sep 2016 Note was $430,896.
Unsecured Convertible Notes Two [Member]
Convertible Promissory Notes (Textual)
Debt instrument interest rate					10.00%
Debt instrument, maturity date					May 19, 2020
Aggregate remaining amount					$ 1,325,000
Conversion price per share of debt, description		The Nov 2018 Note bears interest at 10% per annum. The Nov 2018 Note may be converted into shares of the Company’s common stock at a fixed conversion price of $0.05 per share or 50% of the average three (3) lowest trading prices twenty (20) trading days prior to conversion. The conversion feature of the Nov 2018 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Notes. During the nine months ended September 30, 2019, the Company issued 363,229 shares of common stock upon conversion of principal in the amount of $75,000, plus accrued of $4,439, and a settlement loss of $17,150, with a fair value loss on conversion of debt in the amount of $138,078. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $1,438 during the nine months ended September 30, 2019. The Nov 2018 Note was fully converted as of September 30, 2019.			After the amendment, the conversion price changed to the lesser of $5,600 per share, or b) fifty percent (50%) of the lowest trade price of common stock recorded since the original effective date of this note, or c) the lowest effective price per share granted to any person or entity after the effective date.
Convertible Debt [Member]
Convertible Promissory Notes (Textual)
Aggregate remaining amount					$ 167,048
Description of debt instrument					Note has zero stated interest rate, and the conversion price shall be equal to 75% of the average three lowest last sale prices traded during the 25 trading days immediately prior to conversion.
Conversion of accounts payable into a convertible note					$ 432,048
Percentage of average of lowest closing prices					75.00%
Number of trading days previous to conversion					25 days
Unsecured Convertible Notes Four [Member]
Convertible Promissory Notes (Textual)
Debt instrument interest rate					10.00%
Converted an aggregate principal amount				$ 293,000	$ 81,000
Number of shares converted into common stock					74,014
Recognized interest expense					$ 42,260
Accrued interest					$ 5,903
Conversion price per share of debt, description					The Company's common stock at a variable conversion price of 61% of the lowest one (1) trading day during the ten (10) trading days prior to conversion.
Fair value loss on settlement					$ 40,500
Loss on conversion of debt					$ 99,667
Issued an unsecured convertible promissory notes				$ 20,275
Unsecured Convertible Notes Five [Member]
Convertible Promissory Notes (Textual)
Debt instrument interest rate					10.00%
Additional notes issuance			$ 78,750
Converted an aggregate principal amount			157,500		$ 40,550
Number of shares converted into common stock					76,665
Recognized interest expense					$ 50,702
Accrued interest					$ 5,205
Conversion price per share of debt, description					The second of the two Feb 2018 Notes is secured by assets of the Buyer having a fair market value of at least $78,750. The second of the Feb 2018 Notes was issued on August 23, 2018 in the amount of $78,750. The second of the Feb 2018 Notes may be converted into shares of the Company’s common stock at a conversion price of $0.03 or 50% discount of the lowest trading price during the twenty (20) trading days prior to conversion. The conversion feature of the Feb 2018 Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Feb 2018 Notes. During the period ended June 30, 2019, the Company entered into a settlement agreement with the investor in the amount of $20,275 (50% of the outstanding balance of $40,550), based on the outstanding balance due and payable under the Notes. During the nine months ended September 30, 2019, the Company issued 76,665 shares of common stock, upon conversion of principal in the amount of $40,550, plus accrued interest of $5,205, and a settlement loss of $20,275, with a fair value loss on conversion of debt of $152,056. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $50,702 during the nine months ended September 30, 2019. As of September 30, 2019, the Note was fully converted.
Fair value loss on settlement					$ 152,056
Aggregate principal each amount			$ 78,750
Notes maturity date					Feb. 23, 2019
Unsecured Convertible Notes Six [Member]
Convertible Promissory Notes (Textual)
Debt instrument interest rate					10.00%
Converted an aggregate principal amount					$ 6,523
Number of shares converted into common stock					12,500
Aggregate remaining amount					$ 300,000
Accrued interest					$ 4,727
Conversion into common stock					70,111
Conversion price per share of debt, description	The Company entered into a settlement agreement with the investor in the amount of $570,000, based on the outstanding balance due and payable under the Apr & May 2018 Notes. The Company set up a reserve of 2,630,769 shares of common stock of the Company for issuance upon conversion by the investor of the amounts owed under the Notes, in accordance with the terms of the Notes, including, but no limited to the beneficial ownership limitations contained in the Notes. In addition to the foregoing, upon the sale by the investor of the settlement shares as delivered to the investor by the Company, resulting in total net proceeds less than the settlement value, the investor is entitled to additional settlement shares of the Company’s common stock. If after the investor has sold all settlement shares, the investor delivers a written notice to the Company certifying that the investor is entitled to additional settlement shares of the Company’s common stock (the “Make-Whole Shares”). The number of make-whole shares being equal to the greater of ((i) zero and (ii) the quotient of (1) the difference of (x) the settlement value with respect to each sale of shares by the Investor after the delivery of the Settlement Shares, minus (y) the aggregate net consideration received by the Investor from the resale of all shares of common stock issued by the Company, divided by (2) the average trailing closing price for ten (10) trading days for the shares immediately preceding the date of delivery of the make-whole shares. During the nine months ended September 30,2019, the Company issued 281,788 shares of common stock upon conversion of principal in the amount of $28,185, plus accrued interest of $10,727, with a fair value loss on conversion of debt in the amount of $130,131. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $51,605 during the nine months ended September 30, 2019. As of September 30, 2019, the remaining balance on the Apr & May 2018 Notes were $528,821.
Fair value loss on settlement					$ 16,250
Conversion into common stock value					70,100
Fair value loss on conversion of debt					$ 126,144

Derivative Liabilities (Details

Derivative Liabilities (Details) - Fair market value of the derivative liability [Member]	9 Months Ended
	Sep. 30, 2019
Minimum [Member]
Summary of significant assumptions used in the Binomial lattice valuation model for the derivative
Risk free interest rate	1.55%
Stock volatility factor	129.00%
Weighted average expected option life	1 month
Expected dividend yield	0.00%
Maximum [Member]
Summary of significant assumptions used in the Binomial lattice valuation model for the derivative
Risk free interest rate	1.99%
Stock volatility factor	355.00%
Weighted average expected option life	5 years
Expected dividend yield	0.00%

Derivative Liabilities (Detai_2

Derivative Liabilities (Details Textual) - USD ($)	9 Months Ended
	Sep. 30, 2019	Dec. 31, 2018
Derivative Liabilities (Textual)
Principal amount of convertible promissory notes	$ 460,135
Accrued interest	100,557
Loss on conversion of debt amount	254,585
Fair value of the derivative liability	13,615,889	$ 9,360,204
Fair value loss on settlement	$ 77,924

Restricted Stock and Warrants_2

Restricted Stock and Warrants (Details) - Warrant [Member]	9 Months Ended
	Sep. 30, 2019$ / sharesshares
Number of Warrants
Outstanding - beginning of the period | shares	125,456
Granted | shares
Exercised | shares
Forfeited/Expired | shares	(3,412)
Outstanding - end of the period | shares	122,044
Weighted average exercise price
Outstanding - beginning of the period | $ / shares	$ 480
Granted | $ / shares
Exercised | $ / shares
Forfeited/Expired | $ / shares	240
Outstanding - end of the period | $ / shares	$ 500

Restricted Stock and Warrants_3

Restricted Stock and Warrants (Details 1) - Warrant [Member]	9 Months Ended
	Sep. 30, 2019$ / sharesshares
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Warrants Outstanding	122,044
Warrants Exercisable	122,044
Range One [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercisable Prices | $ / shares	$ 500
Warrants Outstanding	122,044
Warrants Exercisable	122,044
Weighted Average Remaining Contractual Life (years)	2 years 1 month 13 days

Restricted Stock and Warrants_4

Restricted Stock and Warrants (Details Textual) - USD ($)	Aug. 09, 2018	Nov. 10, 2017	Aug. 10, 2016	May 12, 2016	Apr. 19, 2019	Sep. 28, 2018	May 16, 2018	Sep. 30, 2019
Restricted Stock and Warrants (Textual)
Warrants outstanding								$ 0
Restricted Stock Grant Agreement [Member]
Restricted Stock and Warrants (Textual)
Issuance of common stock, shares					30,000
Restricted stock grant agreement, description					The Company's common stock provided certain milestones are met in certain stages; a) If the Company's consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue to the board members and consultants in various amounts an aggregate of 15,000 shares in common stock; b) If the Company's consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company's SEC Reports, the Company will issue to the board members and consultants in various amounts an aggregate of 15,000 shares of its common stock.
Employee and Consultant RSGA [Member] | Restricted Stock Grant Agreement [Member]
Restricted Stock and Warrants (Textual)
Issuance of common stock, shares	4,250					13,500	2,000
Restricted stock grant agreement, description	The Company's common stock provided certain milestones are met in certain stages; a) If the Company's consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue to the employee and consultants in various amounts an aggregate of 2,125 shares in common stock; b) If the Company's consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company's SEC Reports, the Company will issue to the employee and consultants in various amounts an aggregate of 2,125 shares of its common stock.					The Company's common stock provided certain milestones are met in certain stages; a) If the Company's consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue to the consultants in various amounts an aggregate of 6,750 shares in common stock; b) If the Company's consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company's SEC Reports, the Company will issue to the consultants in various amounts an aggregate of 6,750 shares of its common stock	The Company's common stock provided certain milestones are met in certain stages; a) If the Company's consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue to the employee and consultant an aggregate of 1,000 shares in common stock; b) If the Company's consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company's SEC Reports, the Company will issue to the employee and consultant an aggregate of 1,000 shares of its common stock
Third Employee RSGA [Member] | Restricted Stock Grant Agreement [Member]
Restricted Stock and Warrants (Textual)
Issuance of common stock, shares		1,000,000
Restricted stock grant agreement, description		The Company's common stock provided certain milestones are met in certain stages; a) If the Company's consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue to the employee up to 500 shares of its common stock; b) If the Company's consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company's SEC Reports, the Company will issue to the employee up to 500 shares of its common stock
Chief Executive Officer [Member] | Restricted Stock Grant Agreement [Member]
Restricted Stock and Warrants (Textual)
Issuance of common stock, shares			857	857	15,000	15,000
Restricted stock grant agreement, description			The Company's common stock to the CEO provided certain milestones are met in certain stages; a) If the Company's consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue up to 429 shares of its common stock; b) If the Company's consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company's SEC Reports, the Company will issue up to 429 shares of its common stock	the Company's common stock provided certain milestones are met in certain stages; a) If the Company's consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company's quarterly or annual financial statements, the Company will issue up to 429 shares of its common stock; b) If the Company's consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company's SEC Reports, the Company will issue up to 429 shares of its common stock	The Company's common stock to the CEO provided certain milestones are met in certain stages; a) If the Company's consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue up to an aggregate of 7,500 shares of its common stock; b) If the Company's consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company's SEC reports, the Company will issue up to an aggregate of 7,500 shares of its common stock.	The Company's common stock to the CEO provided certain milestones are met in certain stages; a) If the Company's consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue up to 7,500 shares of its common stock; b) If the Company's consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company's SEC Reports, the Company will issue up to 7,500 shares of its common stock
Employees [Member] | Restricted Stock Grant Agreement [Member]
Restricted Stock and Warrants (Textual)
Issuance of common stock, shares				429
Restricted stock grant agreement, description				The Company's common stock to the employee provided certain milestones are met in certain stages; a) If the Company's consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company's quarterly or annual financial statements, the Company will issue to each of the employees up to 214 shares of its common stock; b) If the Company's consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company's SEC Reports, the Company will issue to each of the employees up to 214 shares of its common stock
May RSGA [Member] | Restricted Stock Grant Agreement [Member]
Restricted Stock and Warrants (Textual)
Issuance of common stock, shares							15,000
Restricted stock grant agreement, description							The Company's common stock to the CEO provided certain milestones are met in certain stages; a) If the Company's consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue up to 7,500 shares of its common stock; b) If the Company's consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company's SEC Reports, the Company will issue up to 7,500 shares of its common stock.
Consultants [Member] | Restricted Stock Grant Agreement [Member]
Restricted Stock and Warrants (Textual)
Issuance of common stock, shares			143
Restricted stock grant agreement, description			The Company's common stock provided certain milestones are met in certain stages; a) If the Company's consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue to each of the consultants up to 71 shares of its common stock; b) If the Company's consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company's SEC Reports, the Company will issue to each of the consultants up to 71 shares of its common stock

Revenue from Contracts with C_3

Revenue from Contracts with Customers (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Revenue from Contracts with Customers [Abstract]
Equipment Contracts			$ 1,830,217	$ 2,486,426
Component Sales			730,040	1,003,879
Services Sales			116,176	157,956
Licensing Fees			20,000	30,000
Total	$ 939,468	$ 1,094,118	$ 2,696,433	$ 3,678,261

Revenue from Contracts with C_4

Revenue from Contracts with Customers (Details Textual) - USD ($)	Sep. 30, 2019	Dec. 31, 2018
Revenue from Contracts with Customers (Textual)
Contract assets	$ 13,289	$ 111,001
Contract liability	$ 318,151	$ 112,894

Financial Assets (Details)

Financial Assets (Details) - USD ($)	May 15, 2018	Sep. 30, 2019	Dec. 31, 2018
Financial Assets (Textual)
Convertible note accrued interest		$ 100,557
Financial asset, description	The Company received 4,000 shares of WTII preferred stock for the use of OriginClear, Inc. technology associated with their proprietary electro water separation system. The stock was valued at fair market value of $0.0075 for a price of $30,000 on the date of issuance. The preferred shares are convertible into 4,000,000 shares of common stock.
Preferred shares fair value		$ 14,000	$ 22,800
Convertible Note Receivable [Member]
Financial Assets (Textual)
Purchased of convertible note, percentage		10.00%
Convertible note		$ 80,000
Convertible note price		65.00%
Conversion price per share		$ 0.0001
Convertible note principal amount		$ 80,000
Convertible note accrued interest		$ 33,879
Convertible note receivable, description		The Note bears a default clause, which increases the rate of interest to 20% automatic late fee on the unpaid balance, plus the monthly interest increases to 20%, if the accrued interest is not paid per the agreement every six months. As of September 30, 2019, the issuer defaulted on the convertible note, and was charged $20,980 in interest for the period.

Loans Payable (Details)

Loans Payable (Details) - USD ($)	9 Months Ended
	Sep. 30, 2019	Dec. 31, 2018
Loans Payable (Textual)
Loaned amount	$ 35,000	$ 219,841
Principal payments	48,264
Principal balance	$ 206,577
CEO [Member]
Loans Payable (Textual)
Loaned amount		$ 248,870
Promissory Note Payable [Member]
Loans Payable (Textual)
Description of debt instrument	The Company issued a promissory note on July 18, 2018 for the sum of $75,000. The principal consisted of $67,500 plus a $7,500 origination fee. The interest rate was sixty-nine percent per annum. The monthly payments were $4,318, and the maturity date of the Note was August 1, 2028.
Secured Loans Payable [Member]
Loans Payable (Textual)
Description of debt instrument	Short term loans with various lenders for capital expansion secured by the Company's assets in the amount of $1,749,970, which included finance cost of $624,810. The finance cost was amortized over the terms of the loans, which have various maturity dates ranging from October 2018 through February 2019. The term of the loans ranged from two months to six months. The net balance as of September 30, 2019 was $514,181, less finance cost of $12,566 for a net balance of $501,615.

Capital Leases (Details)

Capital Leases (Details) - USD ($)	Sep. 30, 2019	Dec. 31, 2018
Leases [Abstract]
Capital lease	$ 28,433
Less current portion	9,088
Total long-term liabilities	$ 19,345	$ 26,918

Capital Leases (Details 1)

Capital Leases (Details 1)	Sep. 30, 2019USD ($)
Leases [Abstract]
2019	$ 9,088
2020	9,088
2021	1,169
Total	$ 19,345

Capital Leases (Details Textual

Capital Leases (Details Textual) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2019	Dec. 31, 2018
Capital Lease (Textual)
Capital lease term	60 months
Lease price		$ 1
Equipment lease term	5 years
Capital lease amount	$ 45,440
Description of operating lease	There are no escalation or renewal options associated with this lease. The lease has a purchase option to buy the equipment at the end of the lease for one dollar ($1). The monthly lease payments are $757 per month.
Future minimum lease payments due	$ 28,433

Commitments and Contingencies (

Commitments and Contingencies (Details)	9 Months Ended
	Sep. 30, 2019USD ($)
Commitments and Contingencies (Textual)
Warrant reserve	$ 20,000
McKinney [Member]
Commitments and Contingencies (Textual)
Base rent	$ 4,850

Deferred Revenue (Details)

Deferred Revenue (Details)	Sep. 30, 2019USD ($)
Deferred Revenue (Textual)
Received deposit from customer	$ 71,917

Subsequent Events (Details)

Subsequent Events (Details) - Subsequent Event [Member] - USD ($)	1 Months Ended
	Nov. 14, 2019	Nov. 13, 2019	Oct. 31, 2019	Nov. 11, 2019
Subsequent Events (Textual)
Aggregate principal and interest amount		$ 40,429
Aggregate shares of common stock		703,618	19,341
Shares issued				93,334
Aggregate shares sold	204.75
Investors [Member]
Subsequent Events (Textual)
Aggregate shares sold	409.5
Aggregate purchase price	$ 409,500